https://www.dailyhealthindustry.it/nabriva-lantibiotico-lefamulin-raggiunge-obiettivo-studio-fase-3/ 2017-09-19T14:23:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ricerca-indipendente-approvati-finanziamenti-per-40-studi/ 2017-09-19T15:37:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-enrica-bucchioni-e-il-nuovo-direttore-medico/ 2017-09-20T10:52:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-sudamerica-aggredisce-il-mercato-due-ipo-e-21-fusioni-in-un-anno/ 2017-09-20T10:30:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tesaro-panel-ema-raccomanda-niraparib-carcinoma-ovarico/ 2017-09-20T10:49:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-bene-combo-rituximab-venetoclax-in-studio-fase-3-leucemia-linfocitica-cronica/ 2017-09-20T12:05:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-francese-neovacs-punta-tutto-su-vaccino-contro-il-lupus/ 2017-09-20T12:44:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-italia-andrea-mantovani-direttore-del-value-e-access/ 2017-09-21T07:17:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pronto-anticorpo-trispecifico-per-lhiv-presto-test-sulluomo/ 2017-09-21T14:11:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-per-opdivo-ce-il-si-del-nice/ 2017-09-21T15:03:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-il-difficile-compito-del-nuovo-ceo/ 2017-09-21T16:15:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ai-mercati-emergenti-piacciono-le-big-pharma/ 2017-09-21T16:14:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-nuove-linee-guida-i-reumatologi-li-giudicano-sicuri-e-affidabili/ 2017-09-21T16:41:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-gottilieb-stretta-sui-produttori-di-farmaci-galenici/ 2017-09-21T16:47:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-lancia-primo-sito-web-dedicato-alla-terapia-hdx-emodialisi/ 2017-09-22T12:43:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ce-approva-tocilizumab-per-artrite-a-cellule-giganti/ 2017-09-22T14:08:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-aurobindo-e-fondazione-gates-insieme-per-farmaco-innovativo-hiv-in-africa/ 2017-09-22T16:57:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-studi-post-marketing-farmaci-2-su-dieci-non-vengono-effettuati/ 2017-09-22T14:58:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-da-ue-per-rydapt-leucemia-mieloide-acuta/ 2017-09-22T16:39:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-animal-health-a-fianco-dei-veterinari-del-piacenza-wildlife-rescue-center/ 2017-09-22T16:38:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-rinnovati-i-vertici-delle-sei-associazioni/ 2017-09-25T17:10:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-galenici-lorenzin-approva-nuove-tariffe-did-vendita/ 2017-09-25T16:45:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-italia-pazienti-e-creativi-insieme-per-app-sulle-malattie-rare/ 2017-09-25T11:01:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obamacare-mccain-si-mette-di-traverso-verso-il-fallimento-della-riforma/ 2017-09-25T11:20:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-milano-si-presenta-alla-business-community-internazionale-a-bruxelles/ 2017-09-25T12:52:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-arriva-vaxigrip-tetra-vaccino-quadrivalente-contro-linfluenza/ 2017-09-25T15:50:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-arriva-in-italia-daclizumab-scelrosi-multipla/ 2017-09-25T16:42:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-merck-da-ce-via-libera-a-bavencio-uk-e-germania-i-primi-mercati/ 2017-09-26T10:28:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-pubblicita-in-tv-ai-titoli-di-coda/ 2017-09-26T14:05:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-lancia-start-up-biotech-lavorera-su-farmaci-in-sperimentazione/ 2017-09-26T14:30:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-fda-boccia-sirukumab-artrite-reumatoide/ 2017-09-26T14:48:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-dallimpresa-alla-cultura-un-coro-di-si-per-milano/ 2017-09-26T17:12:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/india-prove-di-sostenibilita-tagli-ai-prezzi-di-stent-e-device/ 2017-09-26T16:45:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-ok-da-fda-a-defibrillatore-ellipse-compatibile-con-rm/ 2017-09-27T12:37:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-unaltra-green-light-per-opdivo-fda-dice-si-a-impiego-nel-tumore-gastrico/ 2017-09-28T13:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-rischio-esodo-impiegati-se-verra-scelta-sede-non-idonea/ 2017-09-27T13:14:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/reuters-ecco-le-100-universita-piu-innovative-nessuna-e-italiana/ 2017-09-27T13:59:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dynavax-pronta-a-lanciare-vaccino-epatite-b/ 2017-09-27T14:25:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-accordo-con-soresa-per-nuovo-modello-acquisti-sanitari/ 2017-09-27T16:07:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/3m-italia-soluzioni-innovative-per-pazienti-e-operatori-sanitari/ 2017-09-27T16:47:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-da-collaborazione-con-arma-dei-carabinieri-nuova-arma-contro-il-crimine/ 2017-09-28T16:25:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/staff-ema-amsterdam-barcellona-o-vienna-per-la-nuova-sede/ 2017-09-29T06:06:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-riforma-sanitaria-rinviata-al-2018/ 2017-09-28T15:01:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-ok-da-ce-a-dupixent-dermatite-atopica/ 2017-09-28T17:23:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-nessun-aumento-dei-prezzi-fino-al-2019/ 2017-09-28T16:34:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boeringher-inghelheim-allo-studio-un-modello-per-i-pazienti-da-trattare-con-jardiance/ 2017-09-28T16:29:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accordo-abbvie-amgen-lancio-usa-del-biosimilare-di-humira-nel-2023/ 2017-09-29T17:12:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-fda-approva-abemaciclib-tumore-al-seno/ 2017-09-29T17:55:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-acquista-alere-e-scorpora-tre-strutture/ 2017-09-29T15:56:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ptc-theapeutics-fda-chiede-altri-studi-per-ataluren-distrofia-di-duchenne/ 2017-09-29T17:52:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-oppiodi-stato-di-washington-fa-causa-a-purdue-pharma/ 2017-09-29T16:36:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-multa-di-260-mln-di-dollari-a-grossista-per-contraffazione-di-farmaci/ 2017-09-29T16:46:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-gli-usa-ordinano-13-milioni-di-dosi-imvamune-vaccino-vaiolo/ 2017-10-02T10:50:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ok-fda-allinsulina-ultrarapida-fiasp/ 2017-10-02T17:42:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/governo-usa-170-mln-di-dollari-per-sviluppo-farmaci-e-vaccini-contro-ebola/ 2017-10-02T14:29:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dynavax-studia-partnership-per-il-lancio-di-heplisav-vaccino-epatite-b/ 2017-10-02T14:54:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nobel-2017-in-medicina-vince-lo-studio-del-ritmo-circadiano/ 2017-10-02T16:18:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-usa-pressioni-per-ridurre-prezzo-zinbryta-biogen/ 2017-10-02T17:09:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-ecco-le-tappe-verso-il-d-day/ 2017-10-03T10:27:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-un-advisory-board-per-studiare-il-comportamento-dei-pazienti/ 2017-10-03T15:26:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/7379/ 2017-10-03T17:54:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-prove-di-dialogo-sullhta-con-gli-stakeholder/ 2017-10-03T15:56:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aaa-italia-ce-approva-radiofarmaco-per-tumori-net/ 2017-10-03T16:31:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzin-farmaci-innovativi-accessibili-a-tutti/ 2017-10-03T16:52:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-saunders-spiega-il-tribal-marketing-per-difendere-i-brevetti/ 2017-10-04T10:44:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-partnership-con-immatics-per-ricerca-cellule-t/ 2017-10-04T10:26:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-massimiliano-boggetti-nuovo-presidente-intervista-esclusiva/ 2017-10-04T12:36:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-punta-sugli-inibitori-tyk2-accordo-con-nimbus/ 2017-10-04T13:11:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-rasi-ripercussioni-sui-farmaci-innovativi-se-si-sbaglia-scelta-nuova-sede/ 2017-10-04T14:18:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccitech-il-primo-vaccino-universale-contro-linfluenza-arriva-alla-fase-due/ 2017-10-04T16:11:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-milano-bene-per-le-infrastrutture-ma-in-pole-position-ce-vienna/ 2017-10-05T16:57:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-a-uppsala-primo-laboratorio-di-stampa-3-d-per-i-medical-device/ 2017-10-05T13:44:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-fda-da-via-libera-a-generico-copaxone-e-teva-protesta/ 2017-10-05T14:07:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-da-fda-terza-indicazione-per-botox-in-medicina-estetica-ok-per-le-rughe-sulla-fronte/ 2017-10-05T14:56:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cantone-anac-approccio-scandalistico-alla-corruzione-in-sanita/ 2017-10-05T16:01:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/washington-e-new-delhi-braccio-di-ferro-per-taglio-prezzi-medical-devices-nel-mercato-indiano/ 2017-10-05T16:12:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-bictegravir-a-basso-costo-nei-paesi-poveri-in-attesa-di-entrare-nei-mercati-usa-e-europa/ 2017-10-06T10:25:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-respinge-lassalto-al-brevetto-di-alimta-pemetrexed/ 2017-10-06T10:43:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dynavax-cercasi-partner-per-lancio-vaccino-heplisav-epatite-b/ 2017-10-06T11:07:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/se-la-pharma-fa-home-made-advertising-il-caso-eli-lilly/ 2017-10-06T14:20:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-tegola-per-teva-e-sempre-da-copaxone/ 2017-10-06T14:46:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetti-il-caso-allergan-scuote-il-congresso-usa/ 2017-10-06T16:18:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-johnson-xarelto-fallisce-trial-per-seconda-indicazione-ma-la-pharma-tedesca-e-ottimista/ 2017-10-09T11:37:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-medical-device-start-up-i-fondi-statali-puntano-sullhealth-economy/ 2017-10-09T12:49:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-italia-funziona-la-produzione-conto-terzi/ 2017-10-09T13:45:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-niente-brexit-fear-100-mln-di-euro-per-stabilimento-a-dublino/ 2017-10-09T14:53:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/distribuzione-farmaci-e-lora-di-amazon/ 2017-10-09T15:28:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/flexion-ok-fda-a-farmaco-non-oppioide-per-dolore-al-ginocchio/ 2017-10-09T16:27:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-in-europa-punta-sul-biologico-350-mln-per-ampliare-il-sito-irlandese/ 2017-10-10T16:03:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-in-usa-petizione-pubblica-per-difendere-victoza-dai-generici/ 2017-10-10T12:12:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zoetis-nasce-primo-campo-macerie-coperto-ditalia/ 2017-10-10T13:24:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/guerre-cyber-attacchi-contenziosi-tre-motivi-per-non-investire-nel-pharma-e-nel-biotech/ 2017-10-10T14:18:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-rare-rhythm-si-quota-in-borsa-e-raccoglie-120-mln-di-dollari/ 2017-10-10T16:36:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-aggiorna-linee-guida-su-etichettatura-eccipienti-medicinali/ 2017-10-10T16:35:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/milano-sede-ema-parte-da-bucarest-il-roadshow-diplomatico/ 2017-10-10T16:00:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spark-fda-decide-su-prima-terapia-genica-per-la-cecita/ 2017-10-11T10:31:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-per-lafrica-con-american-cancer-society-e-clinton-health-initative/ 2017-10-11T16:21:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-gottlieb-smentisce-voci-di-addio/ 2017-10-11T12:46:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-biocon-fda-chiede-chiarimenti-su-biosimilare-di-neulasta-amgen/ 2017-10-11T14:06:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-nel-2018-vendita-della-bu-consumer-healthcare/ 2017-10-11T16:59:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-mossa-solitaria-per-distruggere-lobamacare/ 2017-10-11T15:56:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/advertising-i-flag-sul-prodotto-aumentano-la-fiducia-del-paziente-e-la-argumet-dilution/ 2017-10-12T14:02:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/milano-sede-ema-seconda-tappa-road-map-a-lubiana/ 2017-10-12T14:15:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lincertezza-usa-si-riflette-sulla-filiera-e-il-packaging-e-il-primo-a-pagare/ 2017-10-12T15:13:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obamacare-la-spallata-di-trump-rischia-di-andare-a-vuoto/ 2017-10-12T16:06:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-guida-studio-che-personalizza-rischio-pml-per-chi-assume-natalizumab/ 2017-10-12T16:21:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/flexion-fundraising-in-borsa-per-lanciare-zilretta-artrite-ginocchio/ 2017-10-12T16:34:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-niente-cessione-azioni-a-roche-un-no-da-14-miliardi-di-dollari/ 2017-10-13T13:22:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-punta-sul-vaccino-vaxigrip-tetra-nuovo-stabilimento-in-francia/ 2017-10-13T13:46:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-per-stivarga-ce-lok-del-nice/ 2017-10-13T13:59:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ebola-nejm-bene-i-test-dei-due-candidati-vaccini-uno-e-italiano/ 2017-10-13T14:54:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spark-panel-fda-vota-allunanimita-per-luxturna-terapia-genica-cecita/ 2017-10-13T15:14:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nih-collaborazione-con-11-pharma-per-accelerare-ricerca-immunoncologici/ 2017-10-13T15:38:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-chmp-raccomanda-alecensa-tumore-al-polmone/ 2017-10-16T11:32:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapia-cart-algoritmo-individua-potenziali-sindromi-avverse/ 2017-10-16T12:30:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-usa-gli-spot-tv-resistono-a-settembre-spesi-140-mln-di-dollari/ 2017-10-16T16:17:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-lancia-istep-piattaforma-mobile-per-il-paziente/ 2017-10-16T14:23:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-ok-fda-per-stelara-negli-adolescenti-con-psoriasi-grave/ 2017-10-16T14:38:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-da-aifa-luce-verde-a-spinraza-atrofia-muscolare-spinale/ 2017-10-16T15:25:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-la-lenta-fuga-dallisola-del-medtech-britannico/ 2017-10-17T13:10:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-in-italia-brevetti-in-scadenza-per-un-risparmio-di-400-milioni/ 2017-10-17T13:19:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-per-review-fda-nessun-rischio-per-il-cuore/ 2017-10-17T14:14:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nuovo-dati-a-favore-di-opdivo-yervoy-nel-tumore-al-polmone/ 2017-10-17T14:57:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-prima-offerta-per-la-consumer-health-ma-e-debole/ 2017-10-17T15:14:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-governance-per-le-imprese-di-dispositivi-medici/ 2017-10-17T15:32:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-in-attesa-dellfda-ok-del-canada-a-vaccino-shingrix/ 2017-10-18T10:29:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-riva-vp-delloncologia-sara-il-regista-del-lancio-della-terapia-cart/ 2017-10-18T10:58:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-anti-cancro-entro-i-prossimi-tre-anni/ 2017-10-18T12:25:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-q3-remicade-resiste-allattacco-dei-biosimilari/ 2017-10-18T12:35:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-giudice-usa-annulla-brevetto-restasis/ 2017-10-18T15:27:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giudice-usa-ribalta-caso-baby-powder-niente-multa-da-72-mln-per-johnson/ 2017-10-18T16:11:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ok-da-fda-a-yescarta-terapia-car-t-per-linfoma-a-grandi-cellule-b/ 2017-10-19T16:58:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-italia-alessandro-cappella-e-il-nuovo-country-manager/ 2017-10-19T13:32:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accelera-per-opdivo-nel-melanoma-ad-alto-rischio-recidiva/ 2017-10-19T13:08:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-gentiloni-due-o-tre-citta-insidiano-miano/ 2017-10-19T16:00:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-in-usa-aumento-antitumorali-supera-tasso-inflazione/ 2017-10-19T15:26:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-per-lynparza-priority-review-da-fda/ 2017-10-19T16:59:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-msd-digital-health-al-servizio-dei-pazienti-al-via-il-percorso-formativo/ 2020-11-10T09:16:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-prepara-il-lancio-di-semaglutide/ 2017-10-20T11:00:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-positivo-il-q3/ 2017-10-20T11:13:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-la-grande-sfida-si-chiama-r-s/ 2017-10-20T12:26:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-consumer-health-reckitt-benckiser-cambia-organizzazione-commerciale-per-acquisirla/ 2017-10-20T13:15:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-abbandona-trial-su-mongersen-malattia-di-chron/ 2017-10-20T16:10:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-a-due-anni-pembrolizumab-raddoppia-la-sopravvivenza-nel-tumore-al-polmone/ 2017-10-20T16:27:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celltrion-remsima-efficace-nella-pibd-pediatrica/ 2017-10-23T13:00:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-codacons-non-vuole-lema-a-milano/ 2017-10-23T13:10:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-stop-alla-produzione-delle-pompe-di-insulina-animas/ 2017-10-23T16:11:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-in-usa-si-concentra-sulle-malattie-croniche/ 2017-10-23T13:59:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-con-lok-fda-a-shingrix-sempre-piu-al-vertice-della-classifica-vaccini/ 2017-10-23T14:43:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-breakthrough-therapy-per-combo-tafinlar-mekinist-melanoma/ 2017-10-23T15:38:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/otsuka-il-punto-sulladpkd-un-convegno-a-roma/ 2017-10-24T16:24:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nuove-possibilita-per-bydureon/ 2017-10-24T16:33:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-restyling-per-la-linea-diabete/ 2017-10-24T13:09:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-de-ruty-e-grespigna-a-capo-di-general-medicines-e-zentiva/ 2017-10-24T13:42:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-cancer-moonshot-e-su2c-lamerican-way-per-salire-nella-reputazione-dei-consumatori/ 2017-10-24T16:25:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-il-nice-raccomanda-strimvelis/ 2017-10-24T15:43:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-q3-salgono-vendite-e-utili-lincognita-alcon/ 2017-10-25T11:13:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-200-mln-di-dollari-per-immunoterapia-nellalzheimer/ 2017-10-25T12:30:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ebola-il-vaccino-parla-anche-cinese/ 2017-10-25T13:35:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-il-q3-di-spinraza-confonde-gli-analisti/ 2017-10-25T14:14:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-emma-wamsley-conquisteremo-lhealth-consumer/ 2017-10-25T15:39:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-ecco-il-nuovo-angiografo-mobile/ 2017-10-25T15:54:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ddl-lorenzin-melazzini-ottima-notizia-per-sanita-e-ricerca/ 2017-10-25T17:12:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-consumer-health-tre-in-pole-position/ 2017-10-26T12:42:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-rivoluzione-robotica-nelle-linee-di-produzione/ 2017-10-26T12:59:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-con-bexit-dura-test-dei-farmaci-fuori-da-uk/ 2017-10-26T13:25:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-quando-le-ibd-sono-malattie-da-graphic-novel/ 2017-10-26T15:45:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-parte-studio-affinity-per-opcinumab/ 2017-10-26T17:04:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-tiene-la-spesa-farmaceutica-convenzionata-quella-ospedaliera-e-diretta-supera-i-4-mld/ 2017-10-26T17:16:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-effetto-monsanto-sul-q3-vendite-deludenti/ 2017-10-27T12:08:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-consumer-health-lievita-il-prezzo-di-vendita/ 2017-10-27T12:24:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tesaro-da-fda-via-libera-ad-antiemetico-per-via-endovenosa/ 2017-10-27T12:36:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-primo-ok-per-amazon-nella-distribuzione/ 2017-10-27T13:21:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-q3-condizionato-dai-farmaci-anti-hcv-e-arriva-la-concorrenza/ 2017-10-27T16:12:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-q3-al-ribasso-e-revisione-previsioni-di-vendita-2020/ 2017-10-27T14:51:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-bene-il-q3-e-gli-investitori-festeggiano/ 2017-10-30T11:11:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-humira-ancora-top-selling-da-fda-priority-review-per-elagolix-endometriosi/ 2017-10-30T11:30:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-un-q3-allinsegna-di-keytruda-e-dellanimal-health/ 2017-10-31T11:08:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-acquisisce-advanced-accelerator-application/ 2017-10-30T15:45:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-da-fda-ok-provvisorio-a-eagle-pharma-per-copia-di-alimta-pemetrexed/ 2017-10-30T17:46:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-utili-in-crescita-nel-q3/ 2017-10-30T17:07:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-produzione-interna-per-cinryze-angioedema-e-razionalizzazione-degli-impianti/ 2017-10-31T11:48:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-nuovi-dati-per-rilanciare-le-vendite-di-inflectra/ 2017-10-31T13:58:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-con-acqusizione-aaa-nuova-pipeline-per-i-tumori-neuroendocrini/ 2017-10-31T15:13:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-verzenio-best-in-class-nel-tumore-al-seno/ 2017-10-31T15:44:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-a-milano-pronta-delibera-per-pirellone-nuova-sede/ 2017-10-31T16:02:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-limita-tre-farmaci-uno-e-per-la-sclerosi-multipla/ 2017-10-31T16:41:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-q3-giu-anche-per-vicenda-restasis-saunders-amplieremo-attivita/ 2017-11-02T12:27:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-si-del-nice-a-tecentriq-per-pazienti-naive-e-non-sottoposti-a-chemioterapia/ 2017-11-02T12:55:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-e-novartis-no-alluso-off-label-di-avastin-roche/ 2017-11-02T13:34:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/distretto-di-mirandola-hmc-premedical-acquisisce-maggioranza-di-medicina/ 2017-11-02T14:58:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q3-bene-health-innovative-ma-lattenzione-e-su-consumer-healthcare/ 2017-11-02T16:40:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ema-nuovo-accordo-di-mutuo-riconoscimento/ 2017-11-02T16:38:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/indivior-da-panel-fda-primo-ok-a-candidato-contro-dipendenza-da-oppioidi/ 2017-11-02T17:57:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetti-teva-e-lilly-si-scontrano-sullemicrania/ 2017-11-03T15:51:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-gilead-chi-scrivera-il-futuro-della-terapia-dellhiv/ 2017-11-03T16:37:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/strategie-anti-brexit-il-nhs-chiama-andrew-witty/ 2017-11-03T16:51:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/supply-chain-usa-amazon-non-e-una-minaccia/ 2017-11-03T17:12:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obamacare-le-assicurazioni-che-ci-credono-ancora-a-gonfie-vele-nella-trimestrale/ 2017-11-03T17:31:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ce-approva-monosomministrazione-giornaliera-di-rivaroxaban/ 2017-11-03T18:32:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-mercato-usa-in-discesa-libera/ 2017-11-06T10:52:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetti-il-74-per-cento-non-va-ai-nuovi-farmaci/ 2017-11-06T11:29:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/3m-progetto-ia-con-ospedale-niguarda-per-combattere-la-sepsi/ 2017-11-06T17:06:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-stelara-efficace-nel-lupus-sistemico/ 2017-11-06T14:28:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-boehringer-ingelheim-combo-testa-a-testa-per-la-bpco/ 2017-11-06T15:04:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-da-google-amazon-e-microsoft-muro-sui-dati-di-vendite-farmaci-on-line/ 2017-11-06T16:00:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/distribuzione-farmaci-in-usa-prime-risposte-a-rischio-amazon/ 2017-11-07T14:21:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-kymriah-arriva-sul-tavolo-dellema/ 2017-11-07T14:56:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-xarelto-sul-tavolo-dellema-come-trattamento-dellaterosclerosi/ 2017-11-07T14:55:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-si-avvicina-il-momento-della-verita/ 2017-11-07T15:16:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-da-fda-per-zelboraf-e-per-alecensa-come-trattamento-di-prima-scelta/ 2017-11-07T17:14:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-flop-di-addyi-la-pillola-rosa-torna-ai-vecchi-proprietari/ 2017-11-07T20:29:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eoc-pharma-32-mln-di-dollari-per-mettere-su-mercato-asiatico-6-antitumorali/ 2017-11-08T12:17:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-e-portal-unite-per-sviluppare-sistema-infusione-senzago/ 2017-11-08T12:33:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-buco-da-347-miliardi-di-dollari-sempre-piu-profondo/ 2017-11-08T17:17:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-andamento-lento-per-kybella/ 2017-11-08T15:45:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-italia-puntare-sulla-value-based-healthcare-per-sanita-sostenibile/ 2017-11-08T17:16:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-funziona-la-cura-papa/ 2017-11-08T17:43:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-bene-il-candidato-per-la-dengue-ma-il-mercato-e-difficile/ 2017-11-09T11:34:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-bene-il-q3-ma-gli-investitori-sono-scettici/ 2017-11-09T18:50:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-il-nice-dice-no-a-stivarga-tumore-al-fegato/ 2017-11-09T19:15:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-domanda-a-ema-per-dosaggio-vascolare-rivaroxaban/ 2017-11-09T19:08:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-nuovi-dati-favorevoli-per-ustekinuamb-nella-malattia-di-chron/ 2017-11-09T21:51:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-fda-via-libera-a-farmaco-glaucoma-nato-in-italia/ 2017-11-09T19:46:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-bene-il-q3-e-crestor-resiste/ 2017-11-10T11:48:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-a-nicoletta-luppi-il-premio-minerva-donna-deccellenza/ 2017-11-10T13:27:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-il-20-si-decide-sara-un-bagno-di-sangue/ 2017-11-10T15:02:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-per-kisqali-un-futuro-per-pazienti-non-in-menopausa/ 2017-11-10T15:44:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gli-usa-mettono-al-bando-il-fentanyl-non-avra-piu-indicazione-medica/ 2017-11-10T16:43:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-procede-la-ristrutturazione-obiettivo-risparmiare-500-mln-di-dollari-allanno/ 2017-11-10T17:21:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-analsiti-preoccupati-i-dividendi/ 2017-11-13T13:02:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-primi-dati-positivi-per-la-combo-inibitore-ido1-opdivo/ 2017-11-13T13:29:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunomedics-il-nuovo-top-management-arriva-da-celgene/ 2017-11-13T13:50:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-candidato-per-la-degenerazione-maculare-pronto-a-competere-con-bayer-e-regeneron/ 2017-11-13T15:45:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/casa-bianca-ex-presidente-usa-eli-lilly-nuovo-segretario-dipartimento-salute/ 2017-11-13T17:54:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-green-light-dellnhs-per-mavencald-merck-kgaa-e-perjeta-roche/ 2017-11-13T16:44:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-appello-per-milano-sede-ema-aderiscono-28-sigle/ 2017-11-14T15:14:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-lundbeck-una-app-interfaccia-tra-paziente-e-medico-per-gestire-la-depressione/ 2017-11-14T11:51:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ian-read-designa-il-suo-delfino-e-albert-bourla/ 2017-11-14T12:58:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-punta-allestensione-di-ilaris-canakinumab-al-cardiovascolare/ 2017-11-14T13:25:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bill-gates-50-mln-di-dollari-nel-dementia-discovery-fund/ 2017-11-14T14:15:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-internazionale-baxter-40-mila-dollari-per-equipe-centro-accoglienza-milano/ 2017-11-14T16:11:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-da-fda-a-faserna-asma-grave/ 2017-11-15T13:08:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/american-way-per-i-farmaci-basati-sul-microbioma/ 2017-11-15T16:50:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-dopo-il-fallimento-di-prostvac-punta-tutto-sul-candidto-per-rsv/ 2017-11-15T16:19:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilare-remicade-janssen-ritira-la-causa-contro-samsung-e-msd/ 2017-11-15T17:57:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-arriva-in-italia-eliglustat-malattia-di-gucher/ 2017-11-15T17:48:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-esce-da-joint-venture-con-pharma-cinese/ 2017-11-15T17:11:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ok-da-ce-a-triplice-terapia-inalatoria-con-singolo-inalatore-per-bpco/ 2017-11-16T13:24:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-barcellona-di-nuovo-in-lizza-ma-per-milano-ce-lendorsement-tedesco/ 2017-11-16T13:39:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-allopera-con-il-maggio-musicale-fiorentino/ 2017-11-16T13:50:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/theramex-ecco-i-nuovi-vertici/ 2017-11-16T14:25:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardinal-health-a-shangai-pharma-la-distribuzione-dei-farmaci-in-cina/ 2017-11-16T17:00:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/venture-funds-di-sanofi-e-novonordisk-per-inzoyme-pharma-malattie-rare/ 2017-11-16T16:10:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/effetto-amazon-sul-consumer-usa-e-bayer-si-prepara/ 2017-11-16T17:37:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-e-limpegno-per-la-giornata-mondiale-della-prematurita/ 2017-11-17T17:53:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-bruxelles-si-prepara-al-voto-lorenzin-siamo-in-partita/ 2017-11-17T17:49:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-pfizer-e-novartis-tagliano-quelli-di-ibrance-e-kisqali-e-il-nice-dice-ok/ 2017-11-17T13:49:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spark-e-gia-battaglia-sul-prezzo-di-luxturna-terapia-genica-per-la-cecita/ 2017-11-17T14:06:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-da-fda-ok-al-key-pillar-hemlibra-emofilia-a/ 2017-11-17T17:16:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-2017-banco-farmaceutico-foto-dellitalia-in-farmacia/ 2017-11-17T17:25:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-la-grande-attesa-votazioni-al-via-alle-17/ 2017-11-20T10:42:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-la-grande-attesa-2-dublino-malta-e-zagabria-ritirano-candidatura/ 2017-11-20T11:48:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-riforma-fiscale-trump-tenta-lennesima-spallata-ad-obamacare/ 2017-11-20T12:10:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emamilano-al-secondo-turno-con-copenaghen-e-amsterdam/ 2017-11-20T16:24:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-e-iniziato-il-secondo-round-di-votazione/ 2017-11-21T11:06:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-finito-secondo-round-ballottaggio-milano-e-amsterdam/ 2017-11-20T16:39:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-al-via-il-ballottaggio/ 2017-11-21T11:06:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-si-va-al-sorteggio/ 2017-11-21T11:05:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-finisce-il-sogno-di-milano-la-nuova-sede-e-amsterdam/ 2017-11-20T17:50:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-boggetti-delusione-ema-ora-costruire-hub-della-life-science/ 2017-11-20T19:24:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/milano-il-sogno-sfuma-sul-filo-di-lana-ema-ad-amsterdam/ 2017-11-20T18:03:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-scaccabarozzi-ha-comunque-vinto-il-sistema-paese/ 2017-11-20T18:15:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gentiloni-grazie-a-milano-e-a-coloro-che-si-sono-impegnati-per-ema/ 2017-11-20T18:14:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzin-delusione-e-amarezza-ma-su-milano-litalia-ha-fatto-sistema/ 2017-11-20T18:34:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-melazzini-non-si-puo-scegliere-con-il-lancio-della-monetina/ 2017-11-21T11:04:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-accordo-con-sumitomo-dainippon-per-distribuzione-latuda-antipsicotico-atipico/ 2017-11-21T11:21:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-women-health-fa-gola-in-usa-saunders-nessuna-vendita/ 2017-11-21T12:00:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-parte-il-contingency-plan-per-amsterdam-le-questioni-sul-tappeto/ 2017-11-21T16:20:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-italia-luca-ruffini-nuovo-direttore-bu-general-medicine/ 2017-11-21T16:47:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-si-assicura-la-pipeline-cart-di-cue-biopharma/ 2017-11-21T16:50:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-mese-doro-con-tecentriq-e-hemlibra/ 2017-11-21T17:05:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-abbvie-bene-la-combo-rituxan-venclexta-nella-leucemia-linfocitica-cronica/ 2017-11-22T14:17:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-prima-duplice-terapia-per-hiv-e-gsk-va-in-vantaggio-su-gilead/ 2017-11-22T14:46:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novonordisk-punta-al-mercato-dellobesita-con-semaglutide/ 2017-11-22T18:31:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-di-precisione-ci-credono-i-venture-di-amgen-roche-e-msd/ 2017-11-22T15:58:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-darzalex-verso-lapprovazione-in-combo-per-il-mieloma-multiplo/ 2017-11-22T17:29:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-fda-pmda-accordo-per-uniformare-le-valutazioni-dei-nuovi-antibiotici/ 2017-11-22T17:59:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-entro-fine-anno-ricomincia-la-ripresa/ 2017-11-23T16:23:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-il-vaccino-contro-lebola-slitta-al-2018/ 2017-11-23T16:22:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gli-inibitori-sglt2-riducono-i-mace-johnson-eli-lilly-e-astrazeneca-esultano/ 2017-11-23T16:57:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-accordo-con-loxo-oncology-per-sviluppo-di-due-molecole/ 2017-11-23T17:28:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-piano-eradicazione-epatite-c-superati-i-100-mila-pazienti-curati/ 2017-11-23T17:24:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-luce-verde-ad-acam2000-vaccino-contro-il-vaiolo-ex-sanofi/ 2017-11-23T18:40:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-dopo-loxo-oncology-un-altro-accordo-per-la-ricerca-oncologica/ 2017-11-27T12:52:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-una-settimana-dopo-ecco-il-piano-demergenza-per-il-personale/ 2017-11-27T13:35:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-tra-i-possibili-tagli-anche-il-top-manager-michael-hayden/ 2017-11-27T13:48:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-nasce-spin-off-per-ricerca-e-sviluppo-oncologici/ 2017-11-27T13:50:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-niente-piu-combo-per-eylea-degenerazione-maculare/ 2017-11-27T14:20:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aids-vaccine-initiative-pronto-modello-per-un-nuovo-vaccino/ 2017-11-27T14:23:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-fda-spiega-il-razionale-di-vosevi-epatite-c/ 2017-11-27T16:13:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-advair-arranca-per-la-bpco-si-punta-a-estensione-trelegy-ellipta/ 2017-11-28T11:09:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-fresenius-piace-il-mercato-americano/ 2017-11-28T11:29:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-compre-candidato-per-proteggere-tecfidera-sclerosi-multipla/ 2017-11-28T19:18:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-rassicura-gli-investitori-focus-sul-pharma-nonostante-monsanto/ 2017-11-28T18:49:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italia-terra-dei-farmaci-orfani-primo-rapporto-ossfor/ 2017-11-28T18:59:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-partnership-con-intel-e-ndivia/ 2017-11-28T19:11:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/atakeda-italia-il-premio-le-fonti-per-linnovazione-digitale-nel-farmaceutico/ 2017-11-29T16:59:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-arriva-in-gran-bretagna-il-viagra-otc/ 2017-11-29T16:45:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-farmaci-contraffatti-un-business-da-30-miliardi-di-dollari/ 2017-11-29T13:21:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-e-impresa-dellanno-fast-growing-farmaceutico/ 2017-11-29T15:13:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-zika-testa-a-testa-sanofi-takeda/ 2017-11-29T16:51:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-azzerato-il-vertice-via-tre-top-manager-entro-la-fine-dellanno/ 2017-11-29T16:39:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spesa-farmaceutica-vella-aifa-confronto-con-le-regioni/ 2017-11-30T21:20:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-brexit-spiegata-alle-pharma-dallema-un-manuale-di-sopravvivenza/ 2017-11-30T17:55:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-arriva-in-italia-baricitinib-artrite-reumatoide/ 2017-11-30T21:19:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-contro-lhiv-johnson-sanofi-e-gsk-protagoniste/ 2017-11-30T18:28:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-dalla-lezione-di-entresto-la-strategia-per-canakinumab-nel-cardiovascolare/ 2017-11-30T18:45:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-nel-dark-web-in-europa-mercato-da-80-milioni-di-euro/ 2017-12-01T15:32:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-mini-ecg-per-apple-watch/ 2017-12-01T11:01:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gottlieb-fda-early-clinical-data-la-via-da-seguire-per-le-nuove-approvazioni-dei-farmaci/ 2017-12-01T11:37:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-research-award-2017-premiati-quattro-progetti-italiani-under-40/ 2017-12-01T15:36:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-ununica-bu-per-ricerca-e-sviluppo/ 2017-12-01T16:03:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-alla-fine-i-biosimilari-vinceranno-ma-non-basta/ 2017-12-01T16:43:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/editing-genetico-per-il-colesterolo-regenron-e-amgen-alla-finestra/ 2017-12-01T17:16:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-gioacchino-dalo-e-il-patient-advocacy-director/ 2020-11-10T08:24:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-da-fda-indicazione-cardiovascolare-per-repatha-evolocumab/ 2017-12-04T11:52:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-ce-chi-si-preoccupa-genmab-teme-per-darzalex-mieloma-multiplo/ 2017-12-04T13:39:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-stop-a-studio-vaccino-contro-clostridium-difficile/ 2017-12-04T14:27:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-senato-approva-riforma-fiscale-prima-spallata-allobamacare/ 2017-12-04T17:38:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-pharma-oltre-il-social-listening-dati-online-e-offline/ 2017-12-04T17:34:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/porte-girevoli-in-24-ore-andreas-busch-da-bayer-a-shire-sara-il-nuovo-evp/ 2017-12-05T13:47:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-la-svolta-mediatica-di-viiv-healthcare-pubblicita-in-tv-di-triumeq/ 2017-12-05T13:46:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-acquisisce-il-partner-mitobridge-e-punta-sulla-distrofia-di-duchenne/ 2017-12-05T14:13:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-parla-con-mylan-e-sandoz-comincera-dai-generici/ 2017-12-05T14:42:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-ceo-a-cio-ecco-le-20-donne-top-pharma-2017/ 2017-12-05T17:17:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-pronto-primo-modello-per-scongelamento-cellule-crioconservate/ 2017-12-05T17:25:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-fda-approva-ozempic-semaglutide-sinfiamma-il-mercato-dei-glp-1/ 2017-12-06T12:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-guarda-a-oriente-e-installa-a-shanghai-il-jlabs/ 2017-12-06T12:59:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-ema-rivede-esmya-fibroma-allutero-e-in-usa-e-pronta-la-concorrenza/ 2017-12-06T15:46:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-verso-lo-stop-di-xofigo-tumore-alla-prostata-per-estensione-indicazioni/ 2017-12-06T16:08:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-in-calo-le-sottoscrizioni-dei-piani-assicurativi-obamacare/ 2017-12-06T16:29:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-ceo-a-cio-ecco-le-20-donne-top-pharma-2017-parte-seconda/ 2017-12-07T14:15:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-punta-su-tecentriq-contro-il-tumore-al-polmone/ 2017-12-07T14:01:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-spark-funziona-terapia-genica-per-emofilia-b/ 2017-12-07T14:14:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sperimentazione-clinica-trasparente-al-primo-posto-johnson-e-sanofi/ 2017-12-07T15:03:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-governo-uk-vara-piano-per-trattenere-pharma-e-ricerca/ 2017-12-07T16:09:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-funziona-il-vaccino-contro-zika/ 2017-12-07T16:35:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-pronta-bozza-guida-per-sviluppo-farmaci-pediatrici/ 2017-12-10T10:12:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-talazoparib-migliora-la-sopravvivenza-nel-cancro-al-seno/ 2017-12-11T17:59:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-ottimo-2017-e-la-cina-e-piu-vicina/ 2017-12-11T17:31:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nel-carcinoma-gastrico-cyramza-centra-lobiettivo-principale-ma-non-aumenta-la-sopravvivenza/ 2017-12-11T17:18:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-studio-su-tecentriq-individua-resistenza-a-immunoterapici/ 2017-12-11T15:49:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-gu-pubblica-bando-per-ricerca-indipendente/ 2017-12-11T16:32:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-calano-per-la-prima-volta-le-vendite-di-antibiotici-per-gli-animali-della-filiera-alimentare/ 2017-12-11T17:05:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antares-vision-si-espande-in-irlanda/ 2017-12-12T12:27:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-pronta-la-prima-guida-per-luso-degli-anticorpi-monoclonali-in-veterinaria/ 2017-12-12T13:01:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-una-coppia-al-vertice-per-ampliare-la-pipeline-oncologica/ 2017-12-12T14:56:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-bene-kyprolis-in-combo-nel-mieloma-multiplo/ 2017-12-12T16:22:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/agios-da-studio-early-stage-promettenti-risultati-per-ivosidenib-aml/ 2017-12-12T16:48:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2018-anno-di-svolta-nella-terapia-per-il-cancro-al-polmone/ 2017-12-12T18:07:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-continua-il-turnover-lascia-anche-il-presidente-peterburg/ 2017-12-13T13:15:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-pronta-terapia-editing-genetico-per-anemia-falciforme-e-beta-talassemia/ 2017-12-13T13:39:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gottlieb-fda-early-data-anche-per-i-dispositivi-medici/ 2017-12-13T16:11:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-green-light-per-admelog-copia-di-humalog-eli-lilly/ 2017-12-13T18:58:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/indivior-fda-accetta-richiesta-farmaco-sperimentale-per-la-schizofrenia/ 2017-12-13T17:08:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-sede-ema-amsterdam-e-in-ritardo-appello-bipartizan-per-riconsiderare-milano/ 2017-12-13T17:23:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ottimi-risultati-da-yescarta-car-t/ 2017-12-14T13:56:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-outlook-2018-allinsegna-degli-antidiabetici/ 2017-12-14T14:18:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-mantra-usa-dei-medical-device-per-il-nuovo-anno-accessibilita/ 2017-12-14T18:22:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/revance-e-arrivato-il-vero-rivale-del-botox/ 2017-12-14T16:27:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-dopo-inflectra-arriva-ixifi-nuovo-biosimilare-di-remicade-johnson/ 2017-12-14T18:05:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-dati-midstage-postivi-per-cemiplimab/ 2017-12-14T17:54:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nice-raccomanda-imbruvica-johnson-per-il-linfoma-mantellare/ 2017-12-15T12:04:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-e-sviluppo-roi-piu-basso-degli-ultimi-dieci-anni/ 2017-12-15T13:45:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-accordo-con-giapponese-peptidream-per-sviluppo-farmaci/ 2017-12-15T16:21:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-misure-draconiane-per-risparmiare-3-mld-di-dollari/ 2017-12-15T17:41:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-nuovi-sito-per-combattere-lantibiotico-resistenza/ 2017-12-15T18:23:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-sede-ema-lorenzin-se-ritardo-amsterdam-fosse-vero-assegnazione-da-verificare/ 2017-12-15T18:10:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-per-la-nuova-sede-ad-amsterdam-probabile-doppio-trasloco/ 2017-12-15T18:33:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-dopo-fda-ok-da-chmp-per-ozempic-semaglutide/ 2017-12-18T13:58:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-ecco-la-strategia-per-portare-negli-usa-mavenclad-sclerosi-multipla/ 2017-12-18T14:25:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-green-light-da-fda-per-xeljanz-artrite-psoriasica/ 2017-12-18T19:17:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-shire-battaglia-legale-su-hemlibra-emofilia/ 2017-12-18T16:20:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-eskata-primo-trattamento-non-invasivo-per-cheratosi-seborroica/ 2017-12-18T16:45:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-presto-studio-combo-cemiplimab-vaccino-per-tumori-testa-collo/ 2017-12-18T19:21:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-dai-tagli-di-schultz-si-salvano-i-lanci-di-austedo-e-fremazunemab/ 2017-12-19T18:35:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pg-nel-consiglio-di-amministrazione-entra-joe-jimenez-ex-ceo-di-novartis/ 2017-12-19T13:51:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-gedeon-richter-presto-cariprazina-alla-fda-per-la-depressione-bipolare-grave/ 2017-12-19T18:42:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cellule-staminali-avanzano-gli-studi-su-ictus-e-insufficienza-cardiaca/ 2017-12-19T15:37:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-cresce-il-mercato-italiano-nord-in-testa-per-consumi/ 2017-12-19T18:11:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-apparecchiature-diagnostiche-troppo-vecchie-modello-francese-per-premiare-linnovazione/ 2017-12-20T15:33:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spark-ok-a-luxturna-a-quale-prezzo/ 2017-12-20T14:10:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-prima-farmaceutica-italiana-nel-ranking-della-rd-europea/ 2017-12-20T14:08:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/forbidden-words-di-trump-la-reazione-dei-cdc/ 2017-12-20T14:46:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-estende-uso-di-due-antitumorali/ 2017-12-20T15:56:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ancora-poca-sensibilita-sulle-malattie-croniche/ 2020-11-10T08:32:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/presto-in-italia-mercato-generici-competitivo/ 2020-11-10T08:32:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/market-access-e-patient-access/ 2020-11-10T08:32:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/che-market-access-fa-in-italia/ 2020-11-10T08:32:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-humira-re-delle-vendite-anche-nel-2018/ 2017-12-21T15:08:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-chiusura-dello-stabilimento-di-gerusalemme-nonostante-netanyahu/ 2017-12-21T15:24:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-e-pfizer-fda-approva-steglatro-diabete/ 2017-12-21T16:05:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-abbandona-la-ricerca-su-alzheimer-e-parkinson/ 2018-01-08T12:30:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/8396/ 2018-01-08T14:08:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-al-via-studio-per-biosimilare-eylea-regeneron/ 2018-01-08T14:24:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-regeneron-un-miliardo-in-piu-per-lo-sviluppo-di-cemiplimab/ 2018-01-08T16:14:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-acquisizione-impact-biomedicnes-primo-obiettivo-2018/ 2018-01-08T16:03:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-aifa-ok-a-rimborsabilita-di-ibrance-pfizer-per-il-tumore-mammario-metastatico/ 2018-01-08T16:10:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-mette-le-mani-su-tigenix-per-trattamento-con-cellule-staminali/ 2018-01-09T11:54:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2018-e-arrivata-leta-delloro-per-le-ma/ 2020-11-10T08:32:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-arruola-competitor-per-consorzio-sequenziamento-del-genoma/ 2018-01-09T13:49:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-italia-antonio-spera-nuovo-presidente-e-ad/ 2018-01-09T15:11:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-nel-2018-via-libera-a-16-nuovi-farmaci/ 2018-01-09T15:29:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-loxo-oncology-alla-fda-new-drug-application-per-candidato-tumori-fusione-trk/ 2018-01-09T17:01:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-la-grande-rivoluzione-di-emma-walmsley/ 2018-01-10T12:56:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-diagnostics-e-accenture-partnership-per-software-oncologico/ 2018-01-10T14:34:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-usa-con-riforma-fiscale-riparte-il-ma/ 2018-01-10T17:44:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-sotto-la-lente-dingrandimento-le-bu-neuroscienze-e-malattie-rare/ 2018-01-10T17:45:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-fallisce-il-secondo-assalto-alla-biotech-ablynx/ 2018-01-10T17:07:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-il-generico-di-copaxone-ruba-quote-di-mercato-a-teva/ 2018-01-10T17:31:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-silicon-valley-quale-rapporto/ 2018-01-11T14:25:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-attiva-partnership-con-oxford-e-cambridge/ 2018-01-11T15:00:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-un-2018-di-slancio-che-passa-anche-per-le-acqusizioni/ 2018-01-11T16:26:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-pembrolizumab-riduce-del-43-per-cento-rischio-recidiva-dopo-resezione-melanoma/ 2018-01-11T16:57:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/caforio-ceo-bms-futuro-luminoso-per-eliquis/ 2018-01-11T17:28:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-parola-dordine-2018-massimizzare-il-profitto-operativo/ 2018-01-11T18:29:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-in-pole-position-per-la-consumer-health-di-merck-kgga/ 2018-01-12T13:44:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-boheringher-ingelheim-acquistano-library-per-anticorpi-monoclonali/ 2018-01-12T15:21:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-cede-il-business-europeo-dei-generici-alla-finestra-cinque-pharma-indiane/ 2018-01-12T17:10:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-fda-estende-indicazioni-di-lynparza-tumore-al-seno/ 2018-01-13T18:50:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spark-primo-stop-per-luxturna-per-licer-il-prezzo-e-troppo-alto/ 2018-01-13T19:20:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-in-italia-aumentano-gli-studi-clinici/ 2018-01-14T13:41:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-la-ricerca-delude-fallisce-anche-lidalopiridina/ 2018-01-15T11:49:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-siglato-protocollo-tra-regione-toscana-e-bayer/ 2018-01-15T16:59:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-per-opdivo-si-scalda-la-concorrenza-sul-tumore-al-rene/ 2018-01-15T14:56:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-accordo-con-forty-seven-per-testare-combo-con-immunoterapia/ 2018-01-15T17:34:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dynavax-si-prepara-alla-competizione-con-gsk-per-il-vaccino-contro-epatite-b/ 2018-01-15T17:02:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-arriva-in-italia-il-biosimilare-di-insulina-lispro/ 2018-01-15T18:01:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-pasquale-frega-nuovo-country-president/ 2018-01-16T14:35:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/inpeco-group-il-ceo-e-stefano-bordegnoni/ 2018-01-16T11:43:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccitech-per-il-vaccino-antinfluenzale-universale-ce-anche-google/ 2018-01-16T11:58:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-partnership-con-roche-diagnostics-per-soluzioni-digitali/ 2018-01-16T14:29:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-in-italia-aumenta-il-consumo-in-endocrinologia/ 2018-01-16T17:06:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-la-fondazione-roche-un-ponte-tra-istituzioni-e-cittadini/ 2018-01-17T13:12:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-nuovi-poitivi-risultati-per-combo-keytruda-chemioterapia/ 2018-01-17T14:36:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-ente-regolatorio-uk-rassicura-le-pharma-niente-scossoni/ 2018-01-17T14:39:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-attesa-in-usa-per-il-forecast-2018/ 2018-01-17T16:32:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immuno-oncologia-aumentano-i-merge-biotech-cro/ 2018-01-17T16:55:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-settore-florido-e-qualificato-sinergie-con-spin-off-universita/ 2018-01-17T17:11:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-32-milioni-di-americani-in-piu-senza-assicurazione-santaria/ 2018-01-17T18:52:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-per-kymriah-speed-review-in-usa-ed-europa/ 2018-01-18T17:49:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/orizzonte-cinese-per-il-business-diabete-di-johnson/ 2018-01-18T17:11:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-parziale-apertura-a-darzalex-janssen/ 2018-01-18T15:05:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/linglese-hikma-punta-sulla-rd-per-superare-la-crisi-dei-generici/ 2018-01-18T16:12:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-diagnostics-arrivano-in-italia-gli-analizzatori-alinity/ 2020-11-10T08:32:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tribunale-usa-invalida-brevetto-di-zytiga-johnson/ 2018-01-18T17:10:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-biocon-insieme-per-produrre-i-biosimilari-di-prossima-generazione/ 2018-01-19T16:37:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-gruppi-ospedalieri-insieme-per-produrre-generici/ 2018-01-19T13:38:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-giro-di-vite-al-compounding-farmaceutico/ 2018-01-19T16:31:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-2018-anno-di-kyprolis/ 2018-01-19T15:28:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-botox-al-sicuro-dalla-concorrenza-o-no/ 2018-01-19T16:01:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/car-t-gilead-kite-e-pfizer-fanno-fronte-contro-kymriah-novartis/ 2018-01-19T16:30:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-produttivita-quadruplicata-negli-ultimi-10-anni/ 2018-01-22T15:48:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/b-braun-milano-paolo-suzzani-e-il-nuovo-ad/ 2018-01-22T17:08:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-chiesi-al-french-international-summit-di-macron/ 2018-01-22T17:10:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-via-libera-dalla-commissione-europea-a-prevymis-e-un-farmaco-orfano/ 2018-01-22T18:08:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-exelixis-bene-cabozantinib-carcinoma-epatocellulare-in-studio-fase-iii/ 2018-01-22T18:34:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fortune-nella-top-100-cinque-pharma-la-prima-e-johnson/ 2018-01-22T18:27:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-gsk-e-pfizer-piace-molto-twitter/ 2018-01-23T12:29:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-acqusisce-bioverativ-spin-off-di-biogen/ 2018-01-23T14:26:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-crede-nella-terapia-car-t-e-compra-juno-therapeutics/ 2018-01-23T18:03:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-la-strategia-post-humira-passa-per-loncologia/ 2018-01-23T17:03:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-acquista-kite-pharma-e-le-regala-un-sito-di-ricerca-e-sviluppo/ 2018-01-23T18:22:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ptc-emflaza-vola-ma-e-sempre-sulla-graticola-per-il-prezzo/ 2018-01-23T17:48:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-utile-netto-di-77-miliardi-nel-2017/ 2018-01-24T14:05:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/8610/ 2018-01-24T14:42:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-una-survey-per-minimizzare-impatto-brexit/ 2018-01-24T15:46:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-novartis-funziona-il-candidato-contro-lemicrania/ 2018-01-24T17:15:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medicina-di-precisione-marketing-di-precisione-verso-un-futuro-iperpersonalizzato/ 2018-01-24T17:51:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-per-combattere-dipendenza-da-oppiodi-in-campo-anche-gli-infermieri/ 2018-01-24T18:05:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/puma-biotechnology-il-chmp-dice-no-a-neratinib-tumore-al-seno/ 2018-01-25T13:53:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biosimilare-rituxan-efficace-nel-linfoma-follicolare/ 2018-01-25T14:12:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-il-bilancio-2017/ 2018-01-25T14:21:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-smart-working-volontariato-e-welfare-integrativo/ 2018-01-25T15:52:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-rapporto-fda-conferma-sicurezza-rivaroxaban-fibrillazione-atriale/ 2018-01-25T16:29:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-corridor-emirates-attiva-12-stazioni-per-litalia-ci-sono-malpensa-e-fiumicino/ 2018-01-25T16:45:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-e-spark-therapeutics-accordo-di-licenza-per-luxturna/ 2018-01-25T17:11:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-rinuncia-allacquisto-della-bu-consumer-di-pfizer/ 2018-01-26T12:02:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-revlimid-ha-trascinato-il-2017/ 2018-01-26T17:36:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-niente-acquisizioni-per-il-2018-ma-operazioni-mirate/ 2018-01-26T17:21:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-il-momento-dei-social-media-influencer/ 2018-01-26T14:23:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-da-chmp-parere-positivo-per-hemlibra-emofilia-a/ 2018-01-26T17:23:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-il-vaccino-shingrix-supera-lesame-chmp/ 2018-01-26T16:45:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/franz-presidente-roche-con-trump-nuove-opportunita-per-le-pharma/ 2018-01-29T14:13:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aaa-novartis-via-libera-dalla-fda-a-lutathera-tumori-neuroendocrini/ 2018-01-29T14:24:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chmp-parere-positivo-per-lamzede-gruppo-chiesi/ 2018-01-29T16:03:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-e-pfizer-dopo-la-fda-arriva-lok-del-chmp-per-steglatro-diabete/ 2018-01-29T16:25:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trumpcare-new-york-e-minnesota-contro-i-tagli-ai-basic-health-plans/ 2018-01-29T16:47:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-gennaio-ricco-pareri-positivi-per-sette-farmaci/ 2018-01-29T17:16:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-breakthrough-therapy-per-balovaptan-autismo/ 2018-01-30T11:37:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-acquisisce-ablynx-e-completa-la-pipeline-ematologica/ 2018-01-30T12:15:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-per-candidato-vaccino-zika-fast-track-dalla-fda/ 2018-01-30T13:59:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibd-piu-complicanze-post-operatorie-con-vedolizumab-takeda-monitoriamo/ 2018-01-30T14:33:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-berkshire-e-jp-morgan-nasce-nuovo-polo-dellhealthcare-usa/ 2018-01-30T16:47:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-amsterdam-non-e-pronta-sala-pronto-i-ricorsi/ 2018-01-30T17:54:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-confindustria-il-107-del-pil-nazionale-arriva-da-filiera-salute/ 2018-02-02T15:23:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-dallindustria-gli-appelli-pro-riapertura-dossier/ 2018-02-01T11:15:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dallue-la-proposta-per-velocizzare-approvazione-farmaci-e-dispositivi-medici/ 2018-02-01T14:28:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-gli-analisti-prevedono-grosse-acquisizioni-e-fusioni/ 2018-02-01T14:47:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-un-2017-a-stelle-e-strisce-ocrevus-e-tecentriq-i-top-driver-2018-2/ 2018-02-02T14:16:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bharat-biotech-oms-approva-versione-low-cost-dei-vaccini-di-gsk-e-merck/ 2018-02-02T09:45:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/corbus-effetto-trump-per-la-valutazione-di-lenabasum-fibrosi-cistica/ 2018-02-02T13:49:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-usa-un-anno-dopo-niente-paura-a-wall-street/ 2018-02-02T14:15:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tensione-usa-corea-del-nord-aumenta-la-produzione-di-farmaci-contro-le-radiazioni/ 2018-02-02T15:52:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-delude-il-q4-e-per-il-2018-previsioni-poco-brillanti/ 2018-02-02T16:21:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuova-sede-ema-lolanda-si-difende-amsterdam-in-linea-con-il-dossier-presentato/ 2018-02-02T16:47:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-quarto-anno-consecutivo-di-crescita-per-il-2018-lanci-di-nuovi-prodotti/ 2018-02-02T17:08:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-sbanca-in-cina-e-si-accorda-con-alibaba/ 2018-02-05T13:19:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-10-mld-di-dollari-di-buy-back-per-rilanciarsi-nel-2018/ 2018-02-05T18:34:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-keytruda-in-costante-crescita-flat-tax-per-il-2018/ 2018-02-05T14:54:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nuovi-dubbi-su-assegnazione-ad-amsterdam/ 2018-02-05T18:33:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-successo-combo-opdivo-yervoy-in-studio-di-fase-avanzata/ 2018-02-05T16:08:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/due-anni-sulla-pipeline-e-po-lipo-la-strategia-della-biotech-moderna/ 2018-02-05T16:49:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-astellas-ottimi-risultati-per-xtandi-tumore-prostata-verso-lestensione-delle-indicazioni/ 2018-02-06T11:54:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-twitta-contro-il-nhs-e-i-britannici-protestano/ 2018-02-06T15:32:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-funziona-combo-tecentriq-avastin-nel-carcinoma-a-cellule-renali/ 2018-02-06T16:27:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-bene-il-q4-e-candidato-emicrania-raggiunge-gli-obiettivi-clinici/ 2018-02-06T16:56:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-partenship-con-provider-usa-per-pazienti-pre-diabetici/ 2018-02-06T17:38:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-kymriah-efficace-nei-bambini-e-nei-giovani-adulti-con-lla/ 2018-02-06T17:35:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-accelera-per-la-cessione-della-consumer-health-in-europa/ 2018-02-07T16:09:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ozempic-un-potenziale-blockbuster-da-5-miliardi-di-dollari/ 2018-02-07T14:53:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-sopralluogo-commissione-parlamento-ue-entro-la-fine-di-febbraio-chance-per-milano/ 2018-02-07T16:34:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/array-biopharma-ottimi-risultati-per-la-combo-contro-il-melanoma/ 2018-02-07T16:13:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-nel-q4-dimezzate-le-vendite-nel-business-epatite-c/ 2018-02-07T17:02:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-ema-accetta-domanda-per-fremanezumab-emicrania/ 2018-02-07T17:19:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-primo-colpo-2018-fda-approva-triplice-combo-per-hiv/ 2018-02-08T13:38:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-stop-agli-studi-per-tysabri-nellictus-ischemico/ 2018-02-08T15:17:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-onda-lunga-di-crescita-con-malattie-respiratorie-e-hiv/ 2018-02-08T16:34:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-negli-usa-vola-genzyme/ 2018-02-08T16:33:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-maviret-trascina-il-business-dellepatite-c/ 2018-02-08T17:06:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-ecco-le-motivazioni-del-ricorso-del-comune-di-milano/ 2018-02-08T17:22:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-non-ce-pace-possibile-stop-alla-produzione-del-nuovo-farmaco-per-lemicrania/ 2018-02-09T11:48:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-eylea-e-dupixent-oltre-le-aspettative/ 2018-02-09T12:19:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-causa-contro-nuovo-farmaco-di-gilead/ 2018-02-09T14:33:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-il-nice-raccomanda-gazyvaro-linfoma-follicolare/ 2018-02-10T17:33:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-pronta-la-ricetta-per-frenare-costo-dei-farmaci-con-obbligo-di-prescrizione/ 2018-02-09T17:09:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-sala-chiede-accesso-agli-atti-e-audizione-al-parlamento-europeo/ 2018-02-09T17:24:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/siti-web-aziendali-sul-tetto-del-mondo-gsk-al-secondo-posto-bayer/ 2018-02-12T16:56:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-nonostante-dengvaxia-cresce-dell83-per-cento/ 2018-02-12T16:55:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oppiodi-purdue-pharma-smettera-di-promuoverli-negli-usa/ 2018-02-12T17:17:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-sala-in-settimana-partono-richieste-per-laccesso-agli-atti/ 2018-02-12T17:34:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ge-healthcare-ai-giochi-invernali-con-una-piattaforma/ 2018-02-12T17:56:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-farmindustria-siamo-settore-trainante-per-leconomia-italiana/ 2018-02-12T18:11:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-fda-approva-combo-symdeko-per-la-fibrosi-cistica/ 2018-02-13T14:31:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accordo-con-sirenas-per-drug-discovery-sulla-piattaforma-atlantis-in-area-gastro/ 2018-02-13T14:45:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-partnership-tecnologica-con-start-up-per-dati-real-time-sul-diabete/ 2018-02-13T15:05:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cessioni-asset-acquisizioni-licenze-come-migliorare-il-portfolio/ 2018-02-13T16:41:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandiz-novartis-novartis-approva-nuovo-dosaggio-per-biosimilare-copaxone/ 2018-02-13T18:23:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-gates-finanziamenti-a-curevac-per-vaccino-universale-influenza/ 2018-02-13T18:25:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-leuropa-si-prepara-alle-copie-di-herceptin-roche/ 2018-02-14T13:51:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-hubert-de-ruty-nuovo-presidente-e-ad/ 2018-02-14T14:27:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-il-22-febbraio-sopralluogo-commissione-ambiente-ue-ad-amsterdam/ 2018-02-14T14:39:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-re-dei-vaccini-2017/ 2018-02-14T15:45:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-tv-negli-usa-il-binomio-funziona-ancora/ 2018-02-14T18:33:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-innovativi-lorenzin-apre-per-prescrizione-mmg-fnomceo-plaude-iniziativa/ 2018-02-14T19:04:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-cresce-la-spesa-sanitaria/ 2018-02-15T12:37:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-fda-approva-erleada-cancro-alla-prostata/ 2018-02-15T16:34:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-accordo-con-sk-per-preparare-il-vaccino-antinfluenzale-universale/ 2018-02-15T17:18:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-gates-e-novartis-insieme-per-le-malattie-tropicali/ 2018-02-15T17:26:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-acquisisce-biotech-per-sviluppare-test-pre-clinici/ 2018-02-15T17:40:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-entro-15-giorni-commissione-ue-risponde-a-richiesta-sala/ 2018-02-15T18:15:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-la-fda-abbassa-gli-obiettivi-clinici-per-i-nuovi-farmaci/ 2018-02-16T12:36:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-accordo-con-nektar-per-combo-con-yervoy-e-opdivo/ 2018-02-16T13:38:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-celularity-spinout-di-celgene-con-i-big-della-silicon-valley/ 2018-02-16T14:45:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-un-po-di-ossigeno-da-warren-buffet/ 2018-02-16T17:55:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-quasi-due-miliardi-di-dollari-per-i-dati-di-flatiron-health/ 2018-02-17T10:11:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tar-piemonte-legittimo-sostituire-originator-con-biosimilare-in-dermatologia/ 2018-02-17T10:38:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-vende-unita-generici-di-sandoz-negli-usa/ 2018-02-19T13:17:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acordia-quante-pretendenti-al-candidato-inbrija-parkinson/ 2018-02-19T13:39:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-a-imflinzi-per-il-carcinoma-polmonare/ 2018-02-20T15:34:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-europa-estende-vaxigrip-tetra-ai-bambini-dai-6-mesi-in-su/ 2018-02-19T18:34:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consentyx-novartis-migliora-la-qualita-della-vita-a-5-anni-nei-pazienti-con-psoriasi/ 2018-02-19T18:50:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-il-vaccino-varivax-ottiene-stato-di-prequalifica-oms/ 2018-02-20T18:19:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aschimfarma-in-italia-produzione-principi-attivi-vale-oltre-3-miliardi-di-euro/ 2018-02-20T12:13:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lg-chem-il-biosimilare-di-etanercept-e-sicuro-ed-efficace/ 2018-02-20T14:42:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-per-la-ricerca-2017-premiati-8-under-40-sette-sono-donne/ 2018-02-20T18:22:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-sanitaria-usa-governo-vuole-estendere-durata-piani-assicurazioni-brevi-a-12-mesi/ 2018-02-20T17:17:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobomedica-da-prossimo-governo-piano-industriale-per-la-filiera/ 2018-02-20T17:43:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-comune-di-milano-ricorre-a-corte-conti-ue-domani-sopralluogo-ad-amsterdam/ 2018-02-21T17:54:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-novartis-leurordis-company-award-for-innovation/ 2018-02-21T12:14:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-ionis-licenza-da-30-milioni-di-dollari-per-candidato-patologie-renali/ 2018-02-21T12:22:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-vola-grazie-ai-vaccini-antinfluenzali/ 2018-02-21T12:36:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-shopping-in-australia-per-aumentare-pipeline-nellimmunoterapia/ 2018-02-21T13:22:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-stop-a-studio-fase-2-candidato-per-artrite-reumatoide/ 2018-02-21T17:41:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-sbarca-negli-otc-con-il-marchio-basic/ 2018-02-22T13:37:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-cdc-raccomandano-flumist-per-prossima-stagione-influenzale/ 2018-02-22T13:43:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mesoblast-funziona-terapia-cellule-staminali-nella-graft-versus-host/ 2018-02-22T14:58:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biocon-e-mylan-lettera-richiamo-fda-per-sito-produzione-generico-lantus/ 2018-02-22T15:16:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-aspirina-e-xarelto-pari-efficacia-nella-chirurgia-di-anca-e-ginocchio/ 2018-02-22T16:47:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-governo-olandese-siamo-pronti-sala-la-partita-e-aperta/ 2018-02-22T17:43:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-il-ministro-lorenzin-visita-lo-stabilimento-di-modugno-bari/ 2018-02-23T11:24:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-bene-il-primo-studio-fase-iii-di-ozempic/ 2018-02-23T14:04:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-promettente-studio-fase-i-candidato-erk-inibitore/ 2018-02-23T16:10:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/i-settori-di-business-del-futuro-emicrania-e-nash-ma-occhio-ai-prezzi/ 2018-02-23T16:57:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/puma-biotechnology-no-del-chmp-a-neratinib-tumore-al-seno/ 2018-02-23T17:36:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-aumentano-le-reazioni-avversa-a-eylea/ 2018-02-26T14:04:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-lascia-il-vp-meyers-al-sostituto-il-rinnovo-della-pipeline/ 2018-02-26T10:14:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-golden-share-sulla-bpco-con-i-dati-su-ultibro/ 2018-02-26T10:44:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/general-healthcare-chiara-cavallo-chief-strategy-officer-europeo/ 2018-02-26T14:45:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ozempic-gia-piace-in-usa/ 2018-02-26T14:31:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-niente-lattice-nei-vaccini-antinfluenzali-venduti-in-italia-ma-chiedere-sempre-al-medico/ 2018-02-26T14:59:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-profondo-rosso-per-il-nhs-il-deficit-e-di-900-milioni-di-sterline/ 2018-02-26T17:39:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-fda-approva-estensione-uso-di-verzenio/ 2018-02-27T11:50:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-nella-bufera-per-il-prezzo-del-farmaco-contro-la-malattia-di-wilson/ 2018-02-27T13:25:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-orfani-ok-dal-chmp-a-glibenclamide-per-diabete-neonatale/ 2018-02-27T14:15:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ancora-un-accordo-per-ampliare-la-pipeline-car-t/ 2018-02-27T15:08:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-la-decisione-e-prerogativa-del-parlamento-europeo/ 2018-02-27T15:27:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chmp-cinque-farmaci-raccomandati-a-febbraio/ 2018-02-27T16:58:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-e-astrazeneca-insieme-per-combo-vaccino-imfinzi/ 2018-02-28T13:19:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seqirus-allesame-dellema-il-vaccino-quadrivalente-su-colture-cellulari/ 2018-02-28T14:31:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-fda-chiede-ulteriori-dati-su-ozanimod-sclerosi-multipla/ 2018-02-28T15:22:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tesaro-e-roche-per-combo-zejula-tecentriq-cancro-della-vescica/ 2018-02-28T15:38:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-monsanto-ok-dellantitrust-ue-nel-secondo-trimestre-2018/ 2018-02-28T16:31:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-issalute-il-primo-portale-istituzionale-contro-le-fake-news/ 2018-02-28T16:39:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-come-fda-approvazione-farmaci-alzheimer-per-fase-iniziale-malattia/ 2018-03-01T12:26:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nasce-viela-bio-spin-out-con-focus-su-malattie-immunitarie/ 2018-03-01T15:14:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sorrento-therapeutics-fda-approva-cerotto-contro-dolore-da-herpes-zoster/ 2018-03-01T12:56:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cda-ema-locali-di-amsterdam-pronti-entro-novembre/ 2018-03-01T15:24:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-accordo-con-revance-per-biosimilare-di-botox/ 2018-03-01T17:07:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-acquisisce-marco-antonetto-e-linea-prodotti-roche/ 2018-03-01T18:32:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rubius-200-milioni-di-dollari-per-tecnologia-upgrade-di-car-t/ 2018-03-03T19:43:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consumer-health-il-the-day-after-larrivo-di-amazon/ 2018-03-03T18:07:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/real-data-unopportunita-per-gli-studi-clinici-e-per-le-partnership-tech-pharma/ 2018-03-04T20:21:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-la-commissione-europea-dice-si-a-hemlibra-emofilia-a/ 2018-03-03T19:55:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-esmya-sotto-esame-in-usa-e-in-europa/ 2018-03-03T20:20:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/great-place-to-work-2018-quattro-pharma-nella-top-ten/ 2018-03-04T20:20:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boston-scientific-italia-laura-gillio-meina-nuovo-country-leader/ 2018-03-05T16:01:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-pugno-duro-di-trump-nella-guerra-agli-oppioidi/ 2018-03-05T16:36:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-merckkgaa-ok-del-nice-a-bavencio-nel-carcinoma-a-cellule-di-merkel/ 2018-03-05T17:51:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-e-abbvie-ritirano-dal-mercato-zinbryta-sclerosi-multipla/ 2018-03-05T17:04:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-rivoluzione-digitale-di-vas-narasimhan/ 2018-03-05T17:30:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-aifa-valorizzare-la-cultura-del-farmaco-equivalente/ 2018-03-05T17:47:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-theresa-may-media-per-restare-nellema/ 2018-03-06T13:14:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-funziona-il-vaccino-influenzare-sviluppato-su-linea-cellulare/ 2018-03-06T18:10:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ionis-roche-funziona-il-candidato-per-la-malattia-di-huntington/ 2018-03-06T17:30:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannes-lions-health-aaa-cercasi-creativi-per-il-pharma/ 2018-03-06T16:12:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-ok-del-chmp-per-anakinra-malattia-di-still/ 2018-03-06T16:47:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-il-giallo-dellappalto-la-via-andremo-fino-in-fondo/ 2018-03-06T17:11:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-accordo-quadriennale-con-vividion-per-le-small-molecules/ 2018-03-07T13:11:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-laboratories-da-fda-ok-valvola-cardiaca-da-15mm-e-la-piu-piccola-mai-approvata/ 2018-03-07T13:27:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-fda-approva-nuovo-dosaggio-opdivo/ 2018-03-07T15:49:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-la-via-possibile-avvio-dei-negoziati-ma-non-ce-maggioranza-per-cambiare-assegnazione/ 2018-03-07T20:52:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-bene-lo-studio-di-fase-iii-su-tremphya-guselkumab/ 2018-03-07T17:22:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-gsk-guerra-a-colpi-di-studi-per-la-leadership-nel-mercato-dellhiv/ 2018-03-07T20:41:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gottlieb-fda-pharma-ostacolano-i-biosimilari-e-non-abbassano-i-prezzi-dei-farmaci/ 2018-03-08T14:24:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/taimed-fda-approva-nuovo-anticorpo-monoclonale-per-hiv/ 2018-03-08T14:37:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-con-eisai-per-lantitumorale-lenvima/ 2018-03-08T18:54:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spot-tv-msd-e-pfizer-hanno-scommesso-sui-giochi-invernali-di-pyeongchang/ 2018-03-08T18:17:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-accordo-con-science-37-per-tecnologia-negli-studi-clinici/ 2018-03-08T17:22:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-ancora-un-passo-avanti-nellhealthcare-system-usa/ 2018-03-08T16:29:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-cerca-partner-per-sviluppo-farmaci/ 2018-03-09T13:00:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-parere-esperto-scelta-e-procedura-violano-norme-diritto-comunitario/ 2018-03-09T18:08:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/juno-therapeutics-prima-terapia-sperimentale-car-t-allesame-della-fda-cinese/ 2018-03-10T09:15:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-vaccino-antinfluenzale-fluatix-tetra-efficace-nei-bambini-sotto-i-35-mesi/ 2018-03-10T09:14:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-hiv-bene-primo-studio-su-combinazione-agonista-e-anticorpo-sperimentali/ 2018-03-10T09:35:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-da-panel-fda-a-estensione-xeljanz-a-colite-ulcerosa/ 2018-03-10T10:01:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-arriva-a-quota-17-mila-dipendenti/ 2018-03-12T11:45:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-sanofi-bene-praulent-nello-studio-odyssey/ 2018-03-12T13:41:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-sempre-piu-evidenze-per-sgtl2-esultano-az-boehringer-ingheleim-lilly-e-johnson/ 2018-03-12T13:59:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-per-la-late-phase-in-oncologia-arriva-ricercatrice-top/ 2018-03-12T16:22:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/danone-punta-su-probiotici-e-collaborazione-pubblico-privato/ 2018-03-12T18:14:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-industria-e-terziario-sostengono-con-il-comune-di-milano/ 2018-03-13T12:11:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-cambi-ai-vertici-mondiali/ 2018-03-13T12:20:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nuove-chance-dallo-studio-mystic-per-imfinzi/ 2018-03-13T12:52:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-acquista-da-pfizer-candidato-per-schizofrenia/ 2018-03-13T14:01:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-e-boeringher-ingelheim-proseguono-gli-studi-su-jardiance/ 2018-03-13T15:29:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-commissione-ambiente-sede-amsterdam-ma-olanda-copra-tutti-i-costi/ 2018-03-13T15:56:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-entyvio-meglio-della-terapia-con-tnf-alfa-antagonisti-nella-malattia-di-chron/ 2018-03-13T17:15:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ilaris-riduce-rischio-eventi-cardiovascolari/ 2018-03-14T13:17:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cina-la-cfda-cambia-pelle-vendita-e-marketing-farmaci-monitorati-da-agenzie-locali-di-vigilanza/ 2018-03-14T13:28:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-msd-chmp-dice-si-a-lynparza-in-compresse-per-tumore-ovarico/ 2018-03-14T14:01:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-andrew-witty-nuovo-ceo-di-optum-ex-numero-uno-di-gsk/ 2018-03-14T19:05:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-ecco-le-strategie-per-mantenere-la-leadership-di-repatha/ 2018-03-14T17:10:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-in-sedici-centri-ospedalieri-si-somministra-spinraza/ 2018-03-14T18:23:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-dal-parlamento-europeo-si-condizionato-ad-amsterdam/ 2018-03-15T16:21:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-pronto-dispositivo-per-lattivita-fisica-nella-sclerosi-multipla/ 2018-03-15T16:46:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-gottlieb-investire-nel-vaccino-universale-contro-linfluenza-e-cruciale/ 2018-03-15T17:47:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-stipendio-top-per-il-ceo-saunders-nonostante-i-tagli/ 2018-03-15T18:02:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vella-aifa-investire-in-prevenzione-libera-risorse-per-i-farmaci-innovativi/ 2018-03-15T18:21:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-nuovi-dati-di-efficacia-di-xarelto-nelle-arteriopatie-periferiche/ 2018-03-15T18:24:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-ritorna-a-fare-awareness-studiando-gli-spot-tv/ 2018-03-17T11:16:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-2017-fuga-dalla-stagnazione/ 2018-03-17T11:13:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-parte-la-campagna-uk-per-viagra-otc/ 2018-03-17T11:05:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-ha-in-casa-il-competitor-di-soliris/ 2018-03-18T21:07:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-acquisisce-prexton-per-foliglurax/ 2018-03-17T10:55:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emma-walmsley-un-anno-da-ceo-di-gsk/ 2018-03-17T10:53:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-philips-italia-progetto-di-telemedicina-per-patologie-croniche/ 2018-03-19T12:02:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-ok-del-nice-per-keytruda-nel-tumore-alla-vescica/ 2018-03-19T12:18:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/arbor-biotechnologies-individua-nuovo-enzima-per-editing-genetico/ 2018-03-19T13:22:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ionis-nuova-partnership-per-farmaco-malattia-rara/ 2018-03-19T14:59:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-il-top-player-2018-e-ian-read/ 2018-03-19T17:02:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-pugno-duro-contro-gli-oppioidi-pena-di-morte-contro-gli-spacciatori/ 2018-03-19T18:11:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-compra-in-usa-da-five-prime-arriva-candidato-malattie-infiammatorie/ 2018-03-20T14:11:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ancora-buone-notizie-per-ozempic/ 2018-03-20T14:36:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-nuove-misure-per-abbassare-il-prezzo-dei-farmaci/ 2018-03-20T15:35:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/franz-chairman-roche-avanti-tutta-con-la-ricerca-sullalzheimer/ 2018-03-20T17:25:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-combo-tecentriq-chemioterapici-migliora-sopravvivenza-nel-carcinoma-polmonare/ 2018-03-20T17:56:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-linee-guida-per-uso-off-label-per-i-farmaci-delle-cura-palliative/ 2018-03-20T18:40:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/market-access-in-rosa-filippini-sanofi-public-affairs-e-ma-si-fondono/ 2018-03-21T09:08:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-cina-taglia-i-dazi-sui-farmaci-antitumorali/ 2018-03-21T13:27:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-da-monsanto-spin-off-focalizzata-sullediting-genetico-in-agricoltura/ 2018-03-21T13:37:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seattle-genetics-fda-approva-adectris-per-linfoma-di-hodgkin/ 2018-03-21T13:56:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/enthera-partnership-con-biotech-usa-per-piattaforma-anticorpi-monocolonali/ 2018-03-21T14:19:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-studio-conferma-efficacia-di-pradaxa-nella-fibrillazione-atriale/ 2018-03-21T16:30:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-monsanto-via-libera-dallantitrust-ue/ 2018-03-21T17:30:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-partnership-con-microsoft-per-accelerare-diagnosi-patologie-rare/ 2018-03-22T13:50:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-chiesi-cambia-casa-nuova-sede-pronta-nel-2020/ 2018-03-22T15:02:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-obiettivo-2020-per-nuova-pipeline/ 2018-03-22T15:47:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-da-giugno-eric-cornut-presidente/ 2018-03-22T16:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-corsa-europea-stallo-americano/ 2018-03-22T17:27:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-bene-studio-real-world-con-farxiga/ 2018-03-22T18:15:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cdc-robert-redfield-e-il-nuovo-direttore/ 2018-03-23T11:14:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-ok-da-fda-a-ilumya-psoriasi/ 2018-03-23T11:31:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-consumer-health-si-ritira-reckitt-gsk-favorita-per-lacquisto/ 2018-03-23T12:12:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-arriva-in-italia-rixathon-biosimilare-rituximab/ 2018-03-23T14:56:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viiv-healthcare-chmp-raccomanda-juluca-hiv/ 2018-03-23T15:24:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-siponimod-efficace-in-studio-fase-iii/ 2018-03-23T17:07:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clovis-oncology-chmp-raccomanda-rubraca/ 2018-03-26T10:30:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-joint-venture-con-daiichi-sankyo-per-sfondare-in-giappone-con-shingrix/ 2018-03-26T10:51:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-accordo-con-mallinckrodt-per-due-dispositivi-advanced-suregery/ 2018-03-26T19:13:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2018-tanti-i-blockbuster-in-rampa-di-lancio-il-piu-accreditato-e-helimbra/ 2018-03-26T14:22:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-operazione-sicurezza-nel-galenico-solo-prodotti-autorizzati-dallagenzia/ 2018-03-26T14:58:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nel-2017-segnalate-oltre-50-mila-reazioni-avverse-dei-farmaci-veterinari/ 2018-03-26T16:35:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ancora-unevidenza-positiva-per-tecentriq/ 2018-03-27T10:26:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-data-israele-lancia-programma-open-source/ 2018-03-27T11:09:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-fda-aggiorna-etichetta-tresiba-con-dati-su-minor-rischio-ipoglicemia/ 2018-03-27T12:18:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-consumer-health-e-se-la-soluzione-fosse-una-spin-off/ 2018-03-27T12:58:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-cede-quota-jv-con-gsk-si-prepara-al-un-big-takeover/ 2018-03-27T14:48:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-nuovo-position-paper-sui-biosimilari/ 2018-03-27T15:10:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/market-access-in-rosa-patarnello-astrazeneca-ecco-le-sfide-ma-dellazienda-nel-prossimo-futuro/ 2018-03-28T08:38:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ablynx-stop-a-farmaco-per-les/ 2018-03-28T11:14:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/homology-114-mln-di-dollari-per-programmi-di-editing-genomico/ 2018-03-28T13:20:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-con-la-car-t-cambiera-il-modello-di-business/ 2018-03-28T13:48:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-biosimilari-rapporto-rischio-beneficio-uguali-agli-originator/ 2018-03-28T14:28:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aclaris-strategia-influencer-per-il-lancio-di-eskata/ 2018-03-28T16:25:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gottlieb-teme-il-cartello-dei-pbm-contro-i-generici/ 2018-03-29T12:21:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dexcom-da-fda-via-libera-a-monitor-continuo-del-glucosio/ 2018-03-29T17:57:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-vuole-shire/ 2018-03-30T08:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-2017-stellare-stipendio-top-per-il-ceo-caforio/ 2018-03-29T13:44:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/niaid-piattaforme-biotecnologiche-per-dimezzare-sviluppo-vaccini/ 2018-03-29T15:11:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-non-compra-abide-therapeutics-ma-punta-su-un-cadidato-cns/ 2018-03-29T15:52:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/impax-laboratories-20-mln-da-risarcire-per-presunto-accordo-pay-for-delay/ 2018-04-03T09:33:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-dimissioni-improvvise-del-coo/ 2018-04-03T11:22:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-gorsky-scala-la-classifica-dei-ceo-piu-pagati/ 2018-04-03T10:03:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-blincyto-leucemia-uso-esteso-a-pazienti-mrd/ 2018-04-03T10:25:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-riduzione-decessi-con-tafamidis-cardiomiopatia-amiloidotica/ 2018-04-03T11:39:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-antonelli-guidera-loncologia-in-europa/ 2018-04-03T13:35:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pierrel-41-e-in-mano-a-posillipo-bootes/ 2018-04-03T16:32:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-punta-ad-acquisire-il-25-di-allogene/ 2018-04-04T13:16:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-addio-ai-brevetti-di-15-farmaci-nel-2018/ 2018-04-04T11:11:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/market-access-in-rosa-ponzi-bayer-da-market-access-a-patient-access/ 2020-11-10T08:22:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-3-nuove-molecole-sotto-scrutinio-ema/ 2018-04-04T13:47:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-ema-approva-lamzede-alfa-mannosidasi/ 2018-04-04T14:18:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valeant-taglio-netto-allo-stipendio-del-ceo-papa/ 2018-04-04T15:03:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-consumer-health-ce-pg-vendita-o-joint-venture/ 2018-04-05T19:52:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-da-fda-priority-review-per-terapia-leucemia-a-cellule-capellute/ 2018-04-05T10:52:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-cina-nella-guerra-dei-dazi-finiscono-anche-farmaci-e-dispositivi-medici/ 2018-04-05T13:35:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-cymraza-centra-obiettivo-studio-su-carcinoma-epatico/ 2018-04-05T19:53:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-lisraeliana-biondvax-punta-al-vaccino-universale-antinfluenzale/ 2018-04-05T17:09:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-dei-farmaci-2017-anno-flat-ma-non-per-tutti/ 2018-04-05T17:30:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-accordo-con-samsung-bioepis-in-usa-biosimilare-di-humira-solo-da-luglio-2023/ 2018-04-06T13:08:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-berckshire-e-jp-morgan-ecco-cosa-faranno-nellhealthcare-usa/ 2018-04-06T13:23:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-dal-primo-aprile-immettere-un-farmaco-in-europa-costa-di-piu/ 2018-04-06T13:53:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nerviano-medical-sciences-socio-di-maggioranza-cinese-agazzi-confermato-presidente/ 2018-04-06T16:50:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-boggetti-tornare-a-investire-sui-servizi-sanitari-del-territorio/ 2018-04-06T16:33:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ancora-lontana-la-cessione-del-business-generici-in-europa/ 2018-04-06T16:49:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-pfizer-amgen-o-abbvie-chi-comprera-shire-lanalisi/ 2018-04-09T17:06:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/car-t-svolta-usa-medicare-rimborsa-yescarta-e-kymriah/ 2018-04-09T12:43:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-finanzia-e-ospita-start-up-per-studiare-la-sla/ 2018-04-09T14:19:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-primo-trimestre-2018-al-giudizio-degli-osservatori/ 2018-04-09T15:29:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-cina-vara-pacchetto-di-norme-per-proteggere-i-farmaci-generici/ 2018-04-09T15:52:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-keytruda-centra-obiettivo-studio-su-carcinoma-polmonare/ 2018-04-09T16:20:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obamacare-nuova-spallata-di-trump/ 2018-04-10T11:22:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-punta-sulla-terapia-genica-e-acquisisce-avexis/ 2018-04-10T12:28:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-entro-il-30-aprile-la-dichiarazione-per-le-spese-di-promozione/ 2018-04-10T14:23:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-astrazeneca-punta-sulla-nash-preso-candidato-di-ionis/ 2018-04-10T14:53:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-due-biotech-nel-mirino/ 2018-04-10T15:22:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/therapix-funziona-farmaco-cannabinoide-contro-la-sindrome-di-tourette/ 2018-04-10T15:41:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/market-access-in-rosa-moroni-bms-la-nostra-priorita-portare-linnovazione-ai-pazienti/ 2018-04-11T10:31:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-aringhieri-gruppo-dompe-confermato-presidente-gruppo-biotecnologie/ 2018-04-11T10:59:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-il-vaccino-shingrix-conquista-gli-usa/ 2018-04-11T14:00:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-lorenzo-wittum-nuovo-ad/ 2018-04-11T13:59:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-a-houston-il-piu-grande-stabilimento-per-la-terapia-genica/ 2018-04-11T14:19:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loxo-oncology-illumina-accordo-per-messa-a-punto-test-genomico/ 2018-04-11T14:39:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vivactis-entra-in-media-for-health/ 2018-04-12T13:14:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-offensiva-vaccini/ 2018-04-12T13:51:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-consiglio-ue-apre-negoziato-legislativo/ 2018-04-12T14:01:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brexit-i-farmaci-approvati-da-uk-saranno-rivisti-dallema/ 2018-04-12T16:07:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-acquisisce-wilson-therapeutics-e-amplia-pipeline-malattie-rare/ 2018-04-12T17:09:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tar-veneto-respinge-ricorso-di-gilead-per-aggiudicazione-gara-di-farmaco-equivalente/ 2018-04-12T17:50:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-esce-dalle-malattie-rare/ 2018-04-13T16:40:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-geniche-e-pharma-dove-e-il-punto-di-equilibrio/ 2018-04-13T17:06:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/acquisto-shire-takeda-torna-in-pole-position/ 2018-04-13T17:22:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-generici-medicare-gli-americani-cominciano-a-crederci/ 2018-04-13T17:43:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-nuova-sentenza-monstre-117-mln-di-dollari-per-cancro-da-baby-powder/ 2018-04-13T17:53:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-primo-dispositivo-basato-su-intelligenza-artificiale/ 2018-04-14T19:53:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-sugli-otc-di-merck-kgaa/ 2018-04-16T12:57:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-msd-testa-a-testa-per-il-tumore-al-polmone/ 2018-04-16T17:40:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-la-ricetta-del-ceo-narasimhan-per-i-biosimilari-in-usa/ 2018-04-16T13:48:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-a-base-di-cannabis-federfarma-no-a-pubblicita-e-vendita-on-line/ 2018-04-16T15:03:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shire-vende-bu-oncologia-a-servier-per-24-mld-di-dollari/ 2018-04-16T16:23:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/inventiva-36-mln-di-euro-per-sviluppare-candidato-nash/ 2018-04-16T17:26:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-seconda-btd-per-emicizumab/ 2018-04-17T10:41:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-cede-zentiva-ad-advent-international/ 2018-04-17T12:24:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-da-fda-a-opdivo-yervoy-come-trattamento-di-prima-linea-carcinoma-del-rene/ 2018-04-17T13:14:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-e-jenner-institute-al-via-produzione-vaccini-con-adenovirus/ 2018-04-17T14:46:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/general-electric-arrivano-le-kubio/ 2018-04-17T15:31:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/evelo-100-mln-di-dollari-per-studiare-ceppi-microbici-intelligenti/ 2018-04-17T17:01:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-e-illumina-insieme-per-test-e-farmaci-oncologici/ 2018-04-18T17:19:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-biosimilari-ce-il-plauso-della-sifo/ 2018-04-18T11:24:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-niente-distribuzione-dei-farmaci-con-ricetta/ 2018-04-18T12:49:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-il-vaccino-contro-ebola-immunizza-per-due-anni/ 2018-04-18T13:37:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-q1-in-chiaroscuro/ 2018-04-18T14:52:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accordo-sanofi-advent-per-zentiva-la-trattativa-e-ufficiale/ 2018-04-18T15:21:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-partnership-con-croce-rossa-per-assistenza-in-zone-di-guerra/ 2018-04-19T12:43:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-biopharma-italia-andrea-paolillo-nuovo-medical-affairs-director/ 2018-04-19T12:42:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-con-claria-la-dialisi-peritoneale-automatizzata-e-costo-efficace/ 2018-04-19T13:16:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-campagna-multichannel-tutta-al-femminile-per-verzenio/ 2018-04-19T16:01:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-hemlibra-piace-sempre-di-piu/ 2018-04-19T20:21:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-in-gu-rimborsabilita-della-triplice-combo-per-lepatite-c/ 2018-04-19T16:35:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-pg-la-consumer-health-di-merck-kgaa/ 2018-04-20T12:51:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-per-tagrisso-trattamento-di-prima-linea-nel-tumore-al-polmone/ 2018-04-20T11:05:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genedrive-funziona-la-piattaforma-portatile-per-test-rapido-hcv/ 2018-04-20T12:33:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/divulgazione-scientifica-research-gate-paghera-i-diritti-di-autore/ 2018-04-20T13:22:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-aimovig-efficace-nelle-emicranie-farmaco-resistenti/ 2018-04-20T16:25:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-oms-dengvaxia-va-somministrato-a-chi-e-gia-stato-esposto-alla-dengue/ 2018-04-20T16:51:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-cercasi-partner-per-promettente-pipeline/ 2018-04-23T16:47:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ionis-e-biogen-accordo-da-un-miliardo-di-dollari/ 2018-04-23T12:47:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuove-conferme-per-ocrelizumab-smr/ 2018-04-23T16:59:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-siponimod-efficace-nella-disabilita-e-sulle-capacita-cognitive-sm/ 2018-04-23T17:25:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adriana-albini-prima-italiana-nel-board-dellaacr/ 2018-04-23T17:50:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gw-pharmaceutical-panel-fda-dice-si-a-farmaco-a-base-di-cannabidiolo/ 2018-04-23T17:45:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-con-humana-e-curo-nuovo-polo-dei-servizi-ospedalieri/ 2018-04-24T11:06:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-sul-sito-web-elenco-vaccini-autorizzati-in-italia/ 2018-04-24T12:05:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-la-settimana-del-q1/ 2018-04-24T12:34:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-il-brand-enterogermina-compie-60-anni/ 2018-04-24T13:41:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-al-via-ledizione-2018-del-premio-zanibelli/ 2018-04-24T13:23:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-vascutek-e-bolton-medical-nasce-terumo-aortic/ 2018-04-24T15:11:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-moavero-partita-ancora-aperta/ 2018-04-26T13:56:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/universita-europee-la-piu-innovativa-e-belga-nessuna-italiana-in-classifica/ 2018-04-26T16:54:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-rilancia-per-shire-64-miliardi-di-dollari/ 2018-04-26T15:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-ottimo-q1-nonostante-baricitinib/ 2018-04-26T15:32:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-genzyme-alemtuzumab-mantiene-per-sette-anni-gli-effetti-sulla-smrr/ 2018-04-26T15:51:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-con-loncologia-ritorno-al-futuro/ 2018-04-26T16:26:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-da-ce-per-opdivo-in-monoterapia-per-melanoma-avanzato-e-carcinoma-renale/ 2018-04-27T11:32:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-lancia-app-per-monitorare-studi/ 2018-04-27T12:50:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-ce-impegno-comune-contro-morbillo-e-influenza/ 2018-04-27T13:05:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-al-via-candidature-societa-civile-per-consiglio-direttivo/ 2018-05-01T09:58:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-2017-a-gonfie-vele/ 2018-05-01T10:21:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dompe-muore-improvvisamente-lad-eugenio-aringhieri/ 2018-05-01T16:25:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-fda-a-kymriah-per-il-trattamento-del-linfoma-a-grandi-cellule-b/ 2018-05-02T09:50:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-italia-daniela-cianciulli-direttore-market-access-e-relazioni-istituzionali/ 2020-11-10T09:16:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-grande-q1-grazie-a-keytruda/ 2018-05-02T10:47:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-aifa-dice-si-a-erelzi-biosimilare-etanercept/ 2018-05-02T13:19:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-brusca-frenata-di-harvoni-e-sovaldi/ 2018-05-02T13:43:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-cresce-la-specialty-care/ 2018-05-02T14:06:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-tutto-pronto-per-il-cannes-lions-health/ 2018-05-03T11:49:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-crescono-i-glp1/ 2018-05-03T12:11:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q1-fiacco-ian-read-punta-sulla-pipeline/ 2018-05-03T12:47:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-il-bilancio-2017-2/ 2018-05-03T13:18:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/yescarta-e-kymriah-il-prezzo-e-giusto/ 2018-05-03T14:12:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medical-device-lindia-mette-un-tetto-ai-prezzi/ 2018-05-03T15:06:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-car-t-gli-usa-sinterrogano-sulla-sostenibilita/ 2018-05-04T11:40:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gottlieb-fda-trasparenza-sugli-sconti-dei-farmaci/ 2018-05-04T12:34:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-q1-tra-alti-e-bassi-consumer-health-in-restyling/ 2018-05-04T12:57:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-q1-trascinato-da-eylea/ 2018-05-06T09:40:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immunoterapia-e-investitori-rischio-follow-on/ 2018-05-06T09:40:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scaccabarozzi-siamo-gia-industria-4-0/ 2018-05-06T09:38:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assobiomedica-andrea-celli-nuovo-presidente-associazione-elettromedicali/ 2018-05-07T10:05:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-ok-fda-a-darzalex-nel-miieloma/ 2018-05-10T12:09:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-da-aurobindo-offerta-per-i-generici-dermatologici/ 2018-05-10T17:19:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-acquisisce-shire-il-closing-entro-meta-2019/ 2018-05-10T12:31:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-cede-seroquel-a-luye-pharma/ 2018-05-10T12:53:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-lascia-il-cfo-dingemans/ 2018-05-10T13:55:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-fda-a-combo-tafinlar-e-mekinist-per-carcinoma-tiroideo-anaplastico/ 2018-05-10T17:17:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-ottima-performance-della-pipeline-nel-q1/ 2018-05-10T14:14:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-arriva-in-italia-jlab/ 2018-05-11T12:57:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-e-medici-in-usa-piace-chi-produce-contenuti-di-qualita/ 2018-05-11T16:30:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-trump-non-schiaffeggera-le-farmaceutiche-a-dirlo-gli-esperti-del-settore/ 2018-05-11T15:02:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-problemi-alla-produzione-di-epipen-si-scaldano-i-concorrenti/ 2018-05-11T13:28:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sensor-technology-futuro-prossimo-degli-studi-clinici/ 2018-05-11T14:12:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/venture-capital-amazon-e-jp-morgan-presto-il-nuovo-ceo/ 2018-05-11T14:40:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-la-rivoluzione-robotica/ 2018-05-11T15:25:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-nel-q1-vendite-quasi-raddoppiate-rispetto-al-2017/ 2018-05-14T10:02:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-aifa-estende-prescrizione-entresto-ai-geriatri/ 2018-05-14T14:39:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-fansera-fallisce-studio-final-stage/ 2018-05-14T10:19:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aurobindo-tre-competitor-per-i-generici-dermatologici-di-novartis/ 2018-05-14T10:41:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prezzi-farmaci-trump-bacchetta-tutti-ma-solo-a-parole/ 2018-05-14T14:42:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-il-successo-di-gardasil-parla-anche-cinese/ 2018-05-14T12:37:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-ana-gracia-cebrian-a-capo-della-divisione-diabete-e-cardiovascolare/ 2018-05-16T08:35:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-via-libera-da-fda-a-gilenya-per-smr-pediatrica/ 2018-05-15T10:44:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuovo-asset-in-oncologia-arriva-aurka-pharma/ 2018-05-15T11:07:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-in-usa-assalto-dei-generici-a-velcade/ 2018-05-15T13:30:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-cina-punta-sul-biotech-nel-2023-un-impianto-da-500-mila-litri/ 2018-05-15T13:59:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/federfarma-spesa-farmaceutica-boom-dei-generici/ 2018-05-15T15:30:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-ok-della-fda-al-biosimilare-retacrit/ 2018-05-16T10:50:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-gli-hedge-fund-investono-sulle-assicurazioni-sanitarie/ 2018-05-16T11:21:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilead-ad-amsterdam-nuovo-impianto-per-le-terapia-car-t/ 2018-05-16T12:29:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-arriva-in-italia-eversense-xl-primo-sensore-impiantabile-per-la-glicemia/ 2018-05-16T12:47:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/inovio-bene-il-vaccino-anti-hiv-in-studio-fase-1/ 2018-05-16T13:30:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prime-due-anni-dopo-il-bilancio-nel-report-dellema/ 2018-05-16T14:41:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sede-ema-sindaco-sala-audito-dal-comitato-petizioni-del-parlamento-europeo/ 2018-05-16T15:21:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-verso-asco-2018-con-lottima-performance-di-alecensa/ 2018-05-17T13:47:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-botox-ancora-senza-rivali-fda-boccia-candidato-di-evolus/ 2018-05-17T14:42:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-e-nestle-health-science-sinergia-per-il-paziente-chirurgico/ 2018-05-17T19:19:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loxo-oncology-funziona-candidato-nei-tumori-con-errori-del-gene-ret/ 2018-05-17T19:24:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-nuove-evidenze-per-la-combo-keytruda-chemioterapia-nel-carcinoma-polmonare/ 2018-05-17T16:08:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daichii-sankyo-partnership-con-biotech-canadese-per-sviluppo-anticorpi-bispecifici/ 2018-05-17T16:24:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/melazzini-aifa-rivedere-tetti-di-spesa-e-prontuario-per-mantenere-ssn/ 2018-05-18T10:42:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-le-politiche-di-saving-dopo-loperazione-shire/ 2018-05-18T11:13:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-aimovig-ottiene-il-via-libera-da-fda/ 2018-05-18T13:34:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-alle-aziende-usa-ostacolate-i-generici-la-replica-della-phrma/ 2018-05-18T16:36:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-per-le-big-della-gdo-viola-le-norme-antitrust-su-restasis/ 2018-05-18T14:29:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-lancia-la-prima-social-academy-sulla-slaute/ 2018-05-18T17:07:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-trelegy-a-gonfie-vele-nelle-vendite-e-negli-studi/ 2018-05-21T13:30:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-un-nuovo-antinfiammatorio-nella-pipeline/ 2018-05-21T14:09:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-dopo-lettera-fda-sito-pronto-a-riprendere-produzione-fremanezumab/ 2018-05-21T14:27:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-sempre-piu-evidenze-per-emicizumab/ 2018-05-21T14:57:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-e-partita-in-congo-la-campagna-vaccinale-contro-lebola/ 2018-05-21T15:11:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-italia-lancia-portale-sulle-mici/ 2018-05-21T15:26:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-si-rafforza-la-pipeline-ok-fda-a-lokelma/ 2018-05-22T10:44:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-e-ucsf-insieme-per-ricerca-su-cellule-staminali/ 2018-05-22T11:05:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dova-pharma-fda-approva-primo-agonista-recettore-trombopoietina/ 2018-05-22T13:15:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gran-bretagna-obiettivo-50-mila-diagnosi-precoci-di-cancro-il-piano-di-theresa-may/ 2018-05-22T13:26:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/partnership-sarepta-e-myonexus-per-lgmd-con-loro-una-onlus-italiana/ 2018-05-22T14:04:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-usa-alle-prese-con-i-prezzi-di-revlimid-e-pomalyst/ 2018-05-22T16:45:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-nuova-ufa-al-po-di-gallipoli/ 2018-05-23T10:45:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ok-da-fda-a-uso-pediatrico-arnuity-ellipta/ 2018-05-23T17:08:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-espande-la-pipeline-per-la-cura-della-depressione/ 2018-05-23T11:36:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jak-inibitori-nuovi-blockbuster-pfizer-e-abbvie-sulla-buona-strada/ 2018-05-23T13:08:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boeringher-ingelheim-ofev-riduce-la-mortalita/ 2018-05-23T14:23:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-per-symbicort-anti-infiammatorio-al-bisogno-nellasma-lieve/ 2018-05-23T16:12:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-per-fremanezumab-entro-meta-settembre-decisione-fda/ 2018-05-24T11:09:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-per-keytruda-nuovo-successo-in-un-trial/ 2018-05-24T12:26:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/avexis-nuovo-stabilimento-per-terapie-geniche-in-usa/ 2018-05-24T16:34:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-fda-dice-si-a-yonsa-ha-lo-stesso-principio-attivo-di-zytiga/ 2018-05-24T14:27:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-mavenclad-efficace-nei-pazienti-con-sm-ad-elevata-attivita/ 2018-05-24T14:59:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-consumer-healthcare-quante-pretendenti-affare-da-4-mld-di-dollari/ 2018-05-25T15:24:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-responsabile-oncology-cercasi-ad-agosto-lascia-sue-mahony/ 2018-05-25T14:00:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gdpr-cosa-cambia-nella-sanita/ 2018-05-25T15:10:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-commissione-europea-approva-zessly-biosimilare-di-infliximab/ 2018-05-25T15:13:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ad-abbvie-il-premio-emas-italia-2018/ 2018-05-28T07:49:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-imfinzi-continua-a-convincere/ 2018-05-28T12:15:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-ok-fda-a-terapia-sostitutiva-per-malattia-rara/ 2018-05-28T12:31:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/magenta-ipo-da-100-mln-di-dollari-per-diventare-leader-nelle-staminali/ 2018-05-28T14:23:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-studio-unicover-premia-taltz/ 2018-05-29T10:11:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-ottimi-risultati-per-tremphya/ 2018-05-28T15:20:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/commissione-europea-nuova-proposta-su-brevetti-e-generici/ 2018-05-29T10:16:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-entro-il-2019-nuovo-vaccino-contro-rsv/ 2018-05-29T10:34:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-pasteur-premia-la-comunicazione-sui-vaccini-ecco-i-10-finalisti/ 2018-05-29T13:03:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celgene-quale-pipeline-nei-prossimi-anni/ 2018-05-29T14:20:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-biotech-per-il-mercato-cinese-lha-fondata-un-veterano-gsk/ 2018-05-29T15:12:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-i-fondi-di-investimento-guardano-alla-cina/ 2018-05-29T17:11:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-a-fianco-di-operations-smile-italia/ 2018-05-30T13:17:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-due-nuove-btd-per-xalkori/ 2018-05-30T13:29:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-nel-2022-spesa-oncologici-superera-i-200-mld-di-dollari/ 2018-05-30T13:56:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-position-paper-dei-pazienti-reumatici-italiani/ 2018-05-30T16:03:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-alcuni-azionisti-temono-il-dopo-shire/ 2018-05-30T16:45:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-due-passi-falsi-per-darzalex-nel-tumore-al-polmone/ 2018-05-30T17:08:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/allergan-vende-bu-malattie-infettive-e-salute-femminile/ 2018-05-31T11:20:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-inizata-costruzione-nuova-sede/ 2018-05-31T11:55:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ozempic-funziona-anche-la-versione-a-somministrazione-orale/ 2018-05-31T12:13:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trump-fra-due-settimane-prime-pharma-taglieranno-i-prezzi/ 2018-05-31T12:48:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-arriva-il-bollino-di-qualita-delloms/ 2018-05-31T17:55:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gare-di-acquisto-aifa-definisce-criteri-valutazione-equivalenza-terapeutica/ 2018-05-31T13:49:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aiipa-la-poszione-sugli-integratori/ 2018-06-03T15:57:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-accordo-con-universita-texas-per-medicina-traslazionale/ 2018-06-01T14:52:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-lancia-piattaforma-digitale-che-integra-servizi-e-contenuti/ 2018-06-01T15:09:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-partnership-con-nerviano-medical-sciences-per-nuovi-anttumorali/ 2018-06-04T07:54:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-un-ex-pfizer-alla-guida-del-settore-farmaceutico/ 2018-06-01T15:58:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chi-e-giulia-grillo-nuova-ministra-della-salute/ 2018-06-03T15:13:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-italia-drago-vunia-nuovo-gm-e-vice-president/ 2018-06-05T14:13:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-al-via-iii-edizione-premio-in-neurologia-con-la-sin/ 2018-06-05T11:29:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mylan-ok-fda-a-biosimilare-di-pegfilgrastim/ 2018-06-05T18:16:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gottlieb-fda-accelerare-i-tempi-di-approvazione-dei-farmaci-concorrenti/ 2018-06-05T14:34:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-da-ce-a-perjeta-nel-trattamento-adiuvante-carcinoma-mammario-her2-positivo/ 2018-06-05T14:36:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ecco-il-report-della-spesa-faramceutica-2017/ 2018-06-05T15:03:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-italia-al-via-g4a-milan-2018/ 2018-06-06T10:49:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-sara-upadacitinib-il-post-humira/ 2018-06-06T16:15:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-la-nuova-frontiera-sono-i-big-data/ 2018-06-06T12:51:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sistema-salute-in-italia-il-focus-di-academy-of-health-care-management-and-economics/ 2018-06-06T13:39:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loxo-oncology-nuovi-dati-positivi-per-candidato-tumori-ret/ 2018-06-06T16:14:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-celgene-funziona-terapia-car-t-contro-mieloma-multiplo-avanzato/ 2018-06-06T15:15:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-600-mln-di-dollari-da-investire-150-per-le-neuroscienze/ 2018-06-07T12:46:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-usa-calano-i-prezzi-effetto-copay-accumulator/ 2018-06-07T13:01:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-pronto-piano-emergenza-farmaci-post-brexit/ 2018-06-07T13:45:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chmp-a-maggio-raccomandata-lapprovazione-per-9-farmaci/ 2018-06-07T13:53:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-ce-chi-dice-no-ai-buy-back-della-riforma-fiscale-usa/ 2018-06-07T15:50:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-nuovi-dati-real-world-per-giotrif/ 2018-06-07T16:17:45+00:00 monthly 0.2